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INTRODUCTION 
CONJUNCTIVA 
                      It is the mucous membrane covering of the posterior aspect of 
lids and anterior aspect of the eye ball. It joins the above said – hence it is 
conjoin – to join. It encloses a complex space called conjunctival sac which 
is formed between bulbar conjunctiva and palpebral conjunctiva. 
PARTS OF CONJUNCTIVA 
1)  Palpebral conjunctiva    
Marginal , Tarsal, Orbital 
2) Bulbar conjunctiva    
Scleral, limbal 
3)  Forniceal conjunctiva   
 Superior,  Inferior, Lateral, medial 
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BULBAR CONJUNCTIVA 
-  It forms a thin, transparent, easily movable over the loose underlying 
tissue. 
-  It is separated from anterior sclera by episcleral tissue and Tenon„s 
capsule. 
- This Tenon‟s capsule and episcleral tissue is important in excision and 
autograft. The episcleral tissue and Tenon‟s capsule should be 
dissected completely from the overlying pterygium and graft 
dissection. 
- Episcleral tissue should be incorporated with the graft along with the 
sutures for preventing graft retraction. 
-  Limbal conjunctiva is 3mm ridge of bulbar conjunctiva around cornea.  
- At limbus, the epithelium of conjunctiva becomes continuous with that 
of cornea. At the sclera corneal junction the episcleral tissue with 
Tenon‟s form a dense tissue which is strongly adherent underneath 
which gives a good hold for fixation during surgery. 
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PALPEBRAL CONJUNCTIVA 
- Marginal conjunctiva is about 2 mm from the lid margin. It is a 
transitional zone. This part is up to sulcus subtarsalis where the 
perforating vessels emerge and is the common site for foreign body 
lodgement. 
- Tarsal conjunctiva is the thin translucent and highly vascular. It is 
adhered to the tarsal plate. 
- Orbital part of conjunctiva  is that part that is between tarsal plate and 
fornix 
CONJUNCTIVAL FORNIX 
            Conjunctival fornix forms a continuous sac which is broken only at 
the caruncle and at the plica semilunaris. The superior fornix is just above 
the tarsal plate. It is around 10mm from the limbus. Fascial sheaths of 
superior rectus and levator is attached with the conjunctiva . 
This is important while taking a graft from the superior temporal part 
one should be careful in handling this sheath because this helps in 
maintaining the recess for the eye movement. Similarly in the inferior fornix 
a sheath surrounding inferior rectus and oblique is attached to the 
conjunctival fold. This forms the recess of the inferior fornix. Glands of 
Krause are present in the inferior fornix.  
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STRUCTURE  
Epithelium, Adenoid layer and Fibrous layer 
EPITHELIUM 
                       The conjunctival epithelium doesn‟t have a basement 
membrane. It rests over the substantia propria loosely. These epithelial cells 
extends immunological and mechanical protection against injury and 
infection. Forniceal, bulbar conjunctiva is of three layered epithelium. 
Superficial – cylindrical cells, middle - polyhedral cells, deep –cuboidal 
cells. 
 The Limbal conjunctiva is of 10 layered stratified squamous 
epithelial cells.  The Limbal epithelium forms the papillae of Limbal 
palisades of Vogt which provides the germinative zone for corneal 
epithelium. 
GOBLET CELL LAYER  
                The goblet cell of conjunctiva contributes to tear film production 
and stability of the tear film. It is present all over the conjunctiva in between 
the epithelium. These goblet cells are the unicellular glands. These cells are 
formed with in the deepest layers of the basal layer migrate to the superficial 
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part. The goblet cells are round or oval in shape. Mucin secreted by goblet 
cells protects conjunctival and corneal epithelial cells. It helps in stability of 
tear film by lowering surface tension. 
MELANOCYTES  
 It is seen in the limbus, fornix, caruncle and at the site of anterior 
ciliary vessels. 
LANGERHAN CELLS 
- Dendritic Cells are seen in the basal corneal epithelium. They are the 
sentinels. Langerhan cells appear to represent a highly differentiated 
cell line from bone marrow related to monocyte, macrophage, 
histiocytes series, presenting in the mucous membrane, epidermis, 
thymus, lymph nodes.  
- These cells have surface receptors for the FC component of Ig G, the 
third component of compliment and surface HLA –DR [ Ia] antigen. 
Reported to involve in allograft rejection of cornea. 
 
 
 
15 
 
SUBSTANTIA PROPRIA 
                  The adenoid layer and the fibrous layer together forms the 
substantia propria.  
ADENOID LAYER 
                    It contains plenty of immune cells like lymphocytes, plasma 
cells, eosinophils and mast cells. It is also called the lymphoid layer. It 
develops after 2-3 months of birth. 
FIBROUS LAYER 
                     It is thicker than adenoid layer. It is a mesh work of elastic and 
collagen fibres. This layer has sensory nerves and rich vascular network. 
THE CONJUNCTIVAL GLANDS 
                     1) The goblet cells are unicellular mucous glands which are secretary 
and found throughout conjunctiva. Other than these, there are two types of 
glands. 
2) Mucin secreting glands [ crypts of Henle ,glands of Manz] 
3) Accessory lacrimal glands [ glands of Krause and Wolfring] 
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BLOOD SUPPLY TO CONJUNCTIVA  
                    The following three divisions supply conjunctiva  
                        1] Marginal arcade of the eyelid 
                        2] Peripheral arterial arcade of eyelid 
                        3] Anterior ciliary arteries. 
                             Medial and lateral palpebral arteries form the marginal arcade of the 
eyelid. Around a total of 7 muscular arteries gives rise to the anterior ciliary 
artery at least 4 mm from the limbus before piercing sclera. The anterior 
ciliary artery gives off the anterior and posterior conjunctival arteries, which 
forms the peripheral arcade also they anastomose forming the pericorneal 
plexus. 
VENOUS DRAINAGE            
                              The venous blood from the conjunctiva is drained via the 
eyelid venous plexus and they in turn drain into superior ophthalmic veins 
and inferior ophthalmic vein. The circum corneal veins drain into anterior 
ciliary veins. 
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LYMPHATICS 
Lymphatics of conjunctiva are two layered  
   1] superficial 
   2] deep 
              The lateral part of conjunctiva is drained by pre auricular lymph 
nodes. Medial part of conjunctiva is drained by submandibular lymph nodes. 
NERVE SUPPLY 
                           Bulbar conjunctiva is supplied by long ciliary nerves. 
Medial inferior forniceal conjunctiva and palpebral conjunctiva are supplied 
by maxillary division [intra orbital] of trigeminal nerve. The entire palpebral 
conjunctiva is supplied by ophthalmic division of trigeminal nerve.  
CORNEA 
ANATOMY                    
    It is an avascular, transparent part of the eye that contributes to the 
transmission of light and refraction and aids in the visual function. It has 
convex outer surface and concave inner surface. 
MAJOR FUNCTIONS 
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 1] Refraction 
2] Protective interface with environment 
3] Contain the intra ocular pressure. 
LAYERS OF CORNEA 
             Cornea is made up of the following layers. 
1] Epithelium 
2] Bowman‟s membrane 
3] Stromal layer 
4] Descemet‟s membrane 
5] Endothelium. 
STEM CELLS 
                The conjunctival stem cells are distributed thorough out the bulbar 
conjunctiva. These reside in plenty in the conjunctival fornix and posterior 
to lid margin specifically. The stem cells are population of epithelial cells 
that are self renewable. The stem cells are of low mitotic activity. 
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                At least 35% of limbus should be normal for a normal ocular 
resurfacing. And this helps in preventing avascular cornea to become 
vascularised from the conjunctiva. Only the presence of normal Limbal stem 
cells prevents the migration of conjunctival cells named as 
Conjunctivalisation of cornea. 
TEAR FILM 
       The tear film is a combination of product of the lacrimal gland, 
Meibomean glands, and goblet cells. For a normal tear film formation an 
intact epithelial surface of cornea and conjunctiva and its vasculature and its 
innervations are essentials. 
                     This optically clear layer is essential for nourishing and 
protecting the ocular surface, and for good vision and comfort. And also for 
the adequate oxygen supply for the cornea 
It is a tri layered structure  
- The lipid layer - 0.1 micron 
- The aqueous layer – 7 to 10 micron 
- Mucinous layer - 0.2 to 1 micron in cornea, 2 to 7 micron in 
conjunctiva 
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THE MUCIN LAYER 
                        The mucin layer is responsible for the water retentive 
property and in turns helps in wetting of the ocular surface. 
    MUC 5A   – secreted by goblet cells. 
   MUC 1, 4  – Membrane spanning mucin expressed by non goblet 
epithelial cells. 
                      The goblet cells are found throughout the conjunctiva which is 
more in predominance nasally than temporally. When the electrolytes of tear 
film differs, like increase in osmolarity, goblet cells are stimulated. 
                      The goblet cells are stimulated by the sympathetic and para 
sympathetic nerves and sensory stimulation of cornea. The mucous layer is 
spread out evenly by the microplicae and micro villi of cornea and 
conjunctiva. 
THE AQUEOUS LAYER 
The basic secretors of aqueous layer are goblet cells, accessory 
lacrimal glands, oil glands. The reflex secretor of aqueous layer is main 
lacrimal gland. The named accessory glands are gland of Krause, Wolfring 
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and Manz. It forms the 95% of tear film and it provides oxygen to cornea. It 
washes away debris and noxious agents. It contains anti bacterial agents. 
THE LIPID LAYER 
It is secreted by the Meibomean / Zeiss / glands of Moll. It 
limits the anterior end of the tear fluid hence known as Marginal tear strips. 
PTERYGIUM 
             The word pterygium derived from the Greek word „Pteryx‟ 
which means „wing‟. It is the commonest ocular surface disease. It is also 
called „surfer‟s disease‟. Though the disease is aelastotic degenerative of sub 
conjunctival fibrous tissue of inter palpebral conjunctiva, it is characterised 
by proliferation, inflammatory infiltrates, fibrosis, angiogenesis and 
extracellular matrix breakdown.  Pterygium is a common problem in India. 
Excessive exposure to sunlight, wind and sand has association.  
 
EPIDEMIOLOGY 
                    It tend to occur in dry and hot climates and dusty regions, with 
prevalence rate higher in the tropics than in the temperate latitudes with the 
equatorial countries-usually known as Pterygium belt. It is thought to be due 
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to excessive fibro vascular proliferation on the ocular surface due increased 
UV exposures, from climatic factors, aggravated by chronic inflammation 
and micro trauma from environmental factors. 
PREVALENCE 
                  In children, pterygium is uncommon. It usually presents between 
the age of 20 and 50 years. It differs with rural and urban population. People 
who work for extended periods in outdoors [fisherman, farmer, beach goers, 
inuits, snow skiing] with progressive age [cumulative sun exposure] have 
high incidence of pterygium. It is likely to present twice in men than in 
women. 
CAUSES 
 1]  Chronic exposure to UV –B irradiation 
2]  Pingecula 
3]  Localised limbal stem cell anomalies 
4]  p - 53 gene mutation 
5]  Human papilloma viral infection 
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6] Imbalance of tissue inhibitors of metallo proteinase and 
matrix metallo proteins 
PATHOGENESIS 
                     Zehender proposed Pingecula to be a precursor of pterygium 
which was reaffirmed to be a growth of hyaline and elastic tissue along with 
degenerative changes in the conjunctiva that progressively grows into cornea 
and develops into a pterygium. This was a hypothesis by Fuch‟s.  During the 
growth of pterygium, Pingecula is supposed to be found in head of 
pterygium. 
                  Sugar proposed a degenerative change in pterygium that leads to 
hyperplasia and hypertrophy and hyaline deposition that lifts up and 
separates bowman‟s membrane from epithelium. Also the connective tissue 
laid down contracts and pulls them over to the cornea. D‟Ombrien was of 
the opinion that when a pingecula was closer to limbus it becomes 
pterygium. 
                    UV radiation in the early ages of life tends to create 
biochemical, genetic, and morphologic changes that later in life presents as 
pterygium. 
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What happens with UV radiation? 
                  This UV radiation brings about corneal protein denaturation. This 
process leads to antigen antibody reaction, resulting in fibrovascular 
proliferation. Some added unknown factors triggers fibroblasts that 
penetrates layers between epithelium and bowman‟s membrane. 
                Recently the proposal is that p53 mutation the tumour suppressor 
gene play a vital role in the pathogenesis. Together with loss of 
heterozygosity and microsatellite instability pterygium is supported to be a 
benign neoplasm. 
               The etiopathogenesis is not fully understood. So far it is understood 
that certain signalling pathway, which when activated by UV light results in 
activation of mediators responsible for the growth of the pterygium. There is 
also certain genetic implication towards hereditary factors. 
               Molecular genetics reports loss of heterozygosity [LOH], point 
mutation of proto oncogene, such as k-ras and altered expression of tumour 
suppressor gene. Other associations are like frequent detection of HPV 
DNA, other expression of defensins, phospholipase and up regulation of 
growth factors. 
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                    Few studies suggests a relationship with expression of vimentin, 
which is embryologically responsible for the cellular migration of 
keratoblasts hence a form of genetic predisposition. This is supported by 
“congenital pterygium of Imtiaz” seen in infants.  
HISTOPATHOLOGY 
 Histopathologically pterygium is hyper plastic elastotic 
degeneration. It is actually of abnormal elastic fibres that stain for elastin but 
is not degraded by elastase - hence elastotic. It is a conjunctival loose fibrous 
connective tissue with vascular in growth into the cornea invading upto the 
anterior stromal layer destroying Bowman‟s membrane. 
            It is also a sub-epithelial connective tissue hyalinization of 
degenerating collagen tissue. Anatomically pterygium has head, neck, body, 
and cap. An atrophic conjunctival epithelium covers all these layers though 
head is supposed to be a part of cornea, neck a part of limbus, and body a 
Part of the sclera. 
                   The body of pterygium binds with the episcleral tissue, but it 
spare the episcleral tissue. Hence it is mobile over the sclera. Head of 
pterygium prepares path for the pterygium as the fibroblasts advances in 
between epithelium and bowman‟s membrane.  
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                 During this process the Bowman‟s layer of the cornea is pushed 
behind which leads to break up of the layer. These opening in the cornea 
help in the growth of pterygium in to the anterior stromal layer making it 
firmly adherent with it. 
             Body of the pterygium histologically proved to show tubular glands 
and spaces. This together makes the cystic spaces in pterygium. It also 
clearly showed T lymphocytic infiltrations. 
           Histologically primary and recurrent pterygiums were different 
entities. Recurrent pterygium showed no elastotic degeneration. And it is 
firmly adherent throughout its underlying structure. 
MORPHOLOGICAL GRADING 
Madrid group system  
T 1 – Atrophic and transparent form with clearly visible episcleral vessels. 
T 2 – Intermediate form with partially visible vessels. 
 T 3 – Fleshy and opaque form with totally obscured episcleral vessels. 
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CLASSIFICATION AND STAGING  
                      It is classified as progressive, stationary and regressive types. 
PROGRESSIVE PTERYGIUM  
                     It is a very fleshy mass which appears succulent. It does not 
have a Stocker‟s line. This is an actively growing stage of pterygium which 
is fleshy and vascular. The progressive pterygium appears to be inflamed. It 
is also known as „Pterygium vasculosum cornosum or crassum‟. 
STATIONARY PTERYGIUM 
     The vascular appearance is lost in stationary pterygium and develops a 
Stocker‟s line which is deposition of iron into Bowman‟s membrane due to 
pooling of tears. Since rapidly growing part of pterygium doesn‟t allow tear 
to pool around it, iron deposits [Stocker‟s line] is not seen in active growing 
part of pterygium. This type of pterygium stops growing hence it is called as 
stationary. 
REGRESSIVE PTERYGIUM 
                This is a thin, grey, papery, anaemic and membranous pterygium. 
The grey apex appears as a corneal opacity. In real, pterygium never 
becomes smaller and disappears. Regressive stage is due to its appearance. 
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OTHER TYPES OF CLASSIFICATION 
                     Townsend recently classified pterygium based on the 
probability of recurrence into five groups. 
1] Actively growing 
2] Fleshy 
3] Slowly growing 
4] Stationary 
5] Atrophic 
CLINICAL APPEARENCE 
                         Inter palpebral space is where pterygium grows typically 
with a greater significance towards medial conjunctiva than temporal 
conjunctiva. It can also develop superiorly or inferiorly. If it grows so it 
usually is reactive in nature, growing over an area of limbal irritation or 
inflammation. It can also be bilateral.                    
                       The amount of elevation of pterygium can depend on the 
quantity of fibro vascular tissue proliferation. Cystic spaces can be present 
with pterygium which accounts for relative rapid enlargement of pterygium.  
29 
 
PARTS OF PTERYGIUM 
                     Anatomically pterygium is divided into various parts as body, 
neck, head, and cap.   
Body grows over the limbus from the bulbar surface of conjunctiva. It 
usually has semilunar fold and caruncle while it is nasally situated.  
Neck is the part of pterygium overlying the limbus. It is the narrowest part 
that further extends into cornea.  
Head is the most central extension of pterygium. 
Hood is the non vascular fibrous part. 
Cap is the sub epithelial avascular part of pterygium [eye lots of 
Fuch‟s,Fuch‟s island]  usually presents with a Stocker‟s line which is a red 
brown iron line. 
STOCKER‟S LINE – is the iron line of pterygium. The centre of the 
leading edge has the Stocker‟s line, where the tear film is abnormal. 
Fuch‟s patches  They are small gray coloured flaws at the head of the 
pterygium. 
And has superior and inferior edge. 
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Double Pterygium  
Pterygium that presents both temporally and nasally is referred as double 
pterygium. It accounts for 20% of all pterygium. 
Bilateral Pterygium  
Pterygium occurring in both eyes is called as bilateral pterygium. It can be in 
any combination. For example – double pterygium in one eye and the second 
eye with nasal or temporal pterygium, or nasal pterygium in one eye and 
temporal in second eye. It is commonly bilateral. 
recurrent pterygium 
           There are no clear criteria in defining recurrence. For practical 
purposes, it is defined as the regrowth of fibro vascular pterygium like tissue 
that grows after the removal of true pterygium. It usually gets adherent to 
the limbus and anteriorstroma underlying it. It dosen‟t shows elastotic 
degeneration. It involves episcleral, sclera, corneal stroma and rectus muscle 
sheath hence it is firmly adherent with underlying structures. 
             Recurrent pterygium grows over the cornea encroaching the same 
amount as the original lesion or exceeding it. It develops within six months 
after primary surgery and it is more common in individuals of high UV 
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exposure and with aggressive growth pattern. It usually occurs in young 
adults. 
Pseudo Pterygium 
              It lacks adherence to the limbus, it makes a bridge of conjunctiva to 
the corneal surface bridging over the limbus to the corneal surface. Hence a 
probe test is possible. Pseudo pterygium is due to an inflammatory process 
that makes a fold of conjunctiva which is inflamed adhere over denuded 
cornea which may be near the limbus or away towards the centre. 
       It can occur in any meridian. It doesn‟t go with the rule of inter 
palpebral area as in case of true pterygium. It is more commonly unilateral. 
It is usually due to marginal corneal ulceration, peripheral corneal 
degeneration, traumatic or chemical insult.  
           After primary breaking of the pseudo pterygium adhesions, it doesn‟t 
tend to regrow. 
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PSEUDO PTERYGIUM 
 
 
WHY IN INTER PALPEBRAL REGION?   
1) Nose reflects the UV light, which results in the increased actinic 
exposure in the area. 
2) Also through the Anterior chamber, the light is focussed from temporal 
cornea to nasal conjunctiva.  
3) In addition to the above it was found that the peak light incident nasally 
was 20 times more than that temporally. 
4) This is sometimes termed as „Corneo effect‟ which is due to increased 
UV exposure at the nasal limbus. Cornoe also proposed a theory called 
ophthalmoheliosis, which explains the geometrical exposure factor. 
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MECHANISMS 
1] Stem cell failure. 
2] Anti apoptotic mechanism-viral infection. 
3] Cytokines, growth factors. 
4] A genetic component. 
5] Extracellular matrix remodelling 
SYMPTOMS 
1 Even a small pterygium in many of the patients remains a cosmetic 
blemish otherwise it does not produce any symptoms. It is not 
so common for a pterygium to get inflamed. 
2. Blurring of vision 
3. Irritation / foreign body sensation 
4. Lacrimation 
5. Double vision 
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 DEFECTIVE VISION 
1) A significant growth of pterygium may encroach up on the visual 
axis. Thus affecting the peripheral vision first and later central 
vision. 
2) Astigmatism –  
a. A significant sized pterygium creates a traction due to the 
contractile elements in it leads to flattening of cornea.  
b. Pooling of tear at head of pterygium.  
3) Pre existing corneal astigmatism adds to the above. 
4) Since a pterygium occurs inter palpebrally corneal curvature is 
flattened horizontally producing with the rule astigmatism more 
commonly. 
5) Degree or the amount of astigmatism depends on the total mass or 
the quantity of pterygium, its extension, and leastly its width. 
6) More than  2 D of pterygium is contributed by > 2.2 mm size. And 
total area  >  6.25 mm
2
. 
7) Hence the amount of significant astigmatism produced by 
pterygium itself is an indication for surgery, doesn‟t one need to 
wait till the visual axis encroachment. 
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DIPLOPIA 
   Binocular diplopia is more common with large sized and 
recurrent pterygium. Because of the traction on the conjunctiva it limits eye 
movement opposite to its body. A recurrent pterygium due to its adherence 
to the underlying structure causes double vision. 
DRY EYE SYMPTOMS 
     Factors like UV light exposure, hot, dry climate, and genetic 
predisposition singly or in combination leads to dry eye disease even before 
the genesis of pingecula or pterygium. As dry eye itself induces the 
proliferative growth when not adequately treated, it is wise to grade dry eye 
and treat it the treatment of pterygium successful. 
DIFFERENTIAL DIAGNOSIS 
1) Pingecula 
2) Terriens marginal degeneration 
3) Pseudo pterygium 
4) Traumatic pannus 
5) Conjunctival intra epithelial neoplasia 
6) Phlyctenular conjunctivitis 
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INVESTIGATIONS 
VISUAL ACUITY – Snellen chart 
ASTIGMATISM – Astigmatism is a condition of refraction in which point 
of light cannot be formed on the retina. It may be due to a change in the 
curvature, or of centering, or of refractive index. Instead of a single focal 
point there will be two focal lines which are separated by focal interval. The 
following are the types of astigmatism. 
1) Regular astigmatism 
a) With the rule astigmatism 
b) Against the rule astigmatism 
c) Oblique astigmatism 
d) Bi-oblique astigmatism 
2) Irregular astigmatism 
Other types are 
a) Simple astigmatism 
b) Compound astigmatism 
c) Mixed astigmatism 
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INVESTIGATIONS FOR ASTIGMATISM 
                        The mean corneal curvatures and their differences before and 
after pterygium excision has to be evaluated. 
1)  Retinoscopy /  Automated refractometers 
2)  Keratometry 
3)  Computerised corneal topography 
4)  Videokeratography 
5)  Photokeratoscopy 
6) Others- astigmatic fan test, Jackson cross cylinder test. 
                 For the study purpose retinoscopy, keratometry, and automated 
keratorefractometers or the conventional keratometry using the principle of 
reflection were used for measuring the amount of astigmatism. 
CATARACT AND PTERYGIUM 
                       In tropics like India, cataract grows earlier along with a 
greater incidence of pterygium. The refractive astigmatism induced by a 
surgically significant pterygium influences greatly on the outcome of 
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cataract surgery. A single sitting procedure will be cost effective, reduces the 
work day loss and morbidity. 
 MANAGEMENT OF CATARACT IN PTERYGIUM 
 SIMULTANEOUS OR SEQUENTIAL PTERGIUM AND 
CATARACT SURGERY 
                A small pterygium less than 3 mm does not greatly influence the 
corneal curvature; hence they can be left alone. In such situations cataract 
surgery can be done first later when pterygium excision can be carried out 
when needed. 
              A pterygium of > 3 mm size produce a significant corneal curvature 
change and keratometry values, hence it has to be excised first. Large 
pterygia would undoubtedly induce a corneal astigmatism that will get 
reversed on excision. If in such cases a simultaneous procedure is carried out 
or a pterygium excision after a cataract surgery is done, it would end up in 
post operative refractive surprises due to alteration in the biometry induced 
by pterygium. 
          It is best to wait for 6 to 8 weeks following a pterygium surgery for a 
cataract surgery plan. 
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PLAN 
- Pterygium excision to be done first when the size is >3 mm. 
- Wait for at least 6 weeks following the surgery for the corneal 
topography to get stabilised. 
- All the keratometry and topography to be repeated after 2 weeks and 
before cataract surgery. 
- Even a small surgically insignificant pterygium produces higher order 
aberration – that reduces the quality of vision and contrast sensitivity, 
which are exaggerated by multifocal IOLs. 
- A toric IOL is a better choice. 
DIAGNOSTIC TEST FOR TEAR FILM DYSFUNCTION 
1) Tear meniscus measurement With slit lamp biomicroscopy tear 
meniscus has to be measured. Normally it tear film height measures  
0.2 mm  
2) Tear break up time  
                             It should be performed before instillation of any eye 
drops. Flourescein strip is moistened and applied to the inferior tarsal 
conjunctiva. Several blinks should be made. Under cobalt filter in the 
slit lamp biomicroscopy using a broad beam tear film is examined. 
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The time between the last blink and appearance of the first dark 
discontinuity in the flourescein stained tear film. 
3) Schirmer test   
Whatmann filter paper number 41 is kept in the lower fornix. 
Schirmer test is measuring the wetting of the strip in mm with in the 
first 5 minutes. This test is performed both with and without 
anaesthesia. Less than 5 mm wetting in 5 minutes is abnormal. 
4) Corneal sensation should be assessed.  
SLIT LAMP BIOMICROSCOPY 
It is used in grading of pterygium. The tear film dysfunction has 
to be assessed before deciding about surgery since a dry eye disorder 
essentially will not fit into certain treatment plans. For assessment of other 
ocular co morbid conditions bio microscopic examination has to be done. 
Post operatively it helps in assessment of every parameters and their follow-
up. E.g. graft loss, grading of graft dehiscence, graft retraction and chemosis 
to be examined under slit lamp biomicroscopy.  
A)  Pterygium is graded based on the amount of corneal encroachment as  
Grade 1 the growth in between limbus and papillary region. 
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Grade 2 the growth is upto the visual axis. 
Grade 3 the growth crossing over the visual axis. 
B) Graft dehiscence can be graded as follows 
Grade-0 graft well apposed. 
Grade-1 gaping+, one side of the 4 margins of the graft 
dislaced 
Grade-2 gaping+, 2 sides of the graft displaced 
Grade-3 3 sides of the graft margin displaced. 
Grade-4 completely displaced graft from bed. 
MANAGEMENT 
                Susruta, an Indian and the world‟s first surgeon and 
ophthalmologist was the first who described about pterygium and its surgical 
removal around 1000 B.C. Later his original surgical technique was 
modified by Celsus [29 A.D], Vagblat [3-4
th
 century], Paul [600 A.D], 
Rhazes [932 A.D], Avicenna [1037 A.D], Chakradatta [1060A.D]. 
                Various forms of collyrium of lead, white wine, silver nitrate, bile, 
zinc, lead acetate, iron, mercuric lanoline, cuttlefish  bone, water of 
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Euphrasia had been tried by various practitioners like Demarres, Maitre 
Jean, Saint Yves, Hippocrates,Galen, Celsus, Archigenes, Aetius. 
                 Various ancient surgeons tried lot of surgical techniques and 
about their complications. Around 1AD, Celsus from Rome lifted the 
pterygium from sclera by a scalpel and thread under it. Horsehair was used 
by Paul of Argentina to remove the pterygium. Surgeon from Baghdad, 
named Ali bin Isa classified pterygium into soft and hard varieties and he 
had advised surgery for red and hard form of pterygium. 
                 In 1771, Acrel removed head of pterygium using bistoury. Bare 
sclera excision of Pterygium was introduced by Scarpa during early 1800s. 
In later stages, various surgeons used to scarify pterygium by cauterization 
using various compounds like chromic acid, carbonic snow, silver nitrate, 
nitric acid. 
    To avoid recurrent growth of pterygium, Coccius and Arlt used 
suture techniques along with bare sclera. Mac garis and Ombrien‟s proposed 
the bare sclera technique. Kher suggested suturing of head of the pterygium 
to the inferior fornix. 
 Desmarres tried to mobilize a conjunctival flap into lower 
fornix and transplanted between pterygium and margin of cornea. Upper 
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Forniceal mobilization technique was performed by Terrien. Hobbs used 
galvano cautery and thermal cautery was used by Coe and Loring in 
pterygium removal. In 1876, Klein used free tissue grafts like mucous 
membrane after pterygium excision. Pedicle conjunctival flap graft 
technique was used by Elschnig.     
           Preserved homografts from fetal cornea were the earliest form 
of corneal grafting was done by Morax and Magitot during early 1900s. 
Radiation techniques using radon in preventing recurrence was tried by 
Burnam and Neill. Hughes and Swanberg used beta radiation after to prevent 
recurrence. 
             Kenyon et al was the first to describe conjunctival auto graft and a 
low recurrence rate following the surgery marked a mile stone in pterygium 
surgery. 
MEDICAL MANAGEMENT 
                   The decision about the type of management is influenced by 
both patient‟s and surgeon‟s factor. Main factor that helps in making the 
decision about treatment is the amount of symptoms like irritation, 
inflammatory changes, effect on the vision, and cosmetically how it appears. 
Symptoms like irritation and inflammation used to be self limiting. When it 
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goes beyond self limitance it can be tackled with judicious use of lubricants, 
topical vasoconstrictor, NSAIDS, cyclosporine, or steroids. 
                  Mild to moderate amount of astigmatism due to pterygium can be 
treated with glasses. Regarding contact lenses use scleral lenses are 
theoretically better option to rigid gas permeable lenses. 
                 Many of the Indian patients experience recurrent episodes of the 
same symptoms because of their work associated exposure or environmental 
exposure. Theoretically change of environment, work, or limitation of UV 
light exposure , though helps in limiting or preventing the disease to some 
extent it is not practical many times. Regular use of brimmed hat, dark sun 
glasses, wrap around moisture chamber glasses can be helpful in preventing 
the progression of the disease. 
             According to Rich et al “to manage pterygium, we can incise, 
excise, bury, transplant, graft, freeze, burn, cauterize, diathermize, divulse, 
evulse, chemically assault, irradiate, or simply leave them to fate.” 
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SURGICAL MANAGEMENT 
 Susruta who was the first surgeon ophthalmologist happen to 
first record the disease pterygium and the description about its surgery. All 
the authors who succeeded in describing modified surgery were based on the 
original surgical procedure recommended by Susruta. 
                   The diagnosis of the disease is certain though every aspect of 
pterygium still remains an enigma. There are a number of surgical 
techniques available for its management. The basic surgical principle in its 
management is its removal. But each and every method differs in how the 
conjunctival defect that is created is handled and the adjunctive 
methodology taken in an attempt to give a safer cosmetically acceptable, and 
primly a recurrent free procedure. 
                    Over the centuries a number of procedures have evolved but 
none has completely satisfied the criteria like safer procedure, cosmetically 
acceptable, and importantly a recurrent free procedure. Even in modern days 
a study design for optimal outcome of results are not available due to the 
broad range of geographic location of the disease, differing levels of 
ultraviolet exposure levels, differing techniques of management for 
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dissimilar patients, low levels of compliance of follow up, and inconsistent 
definition of recurrence. 
                    Highlighting the issue about the disease is its notoriety for 
recurrence. Hence recurrence definition and its criteria should be acceptable. 
It includes regrowth of pterygium like fibro vascular growth which crosses 
over the limbus; also it attains the same amount of encroachment as the 
original lesion, or even a regrowth exceeding 1 mm more in to cornea. This 
uprising multitude of treatment plans is all because of this recurrence. 
 INDICATIONS FOR SURGERY 
1) Visually significant astigmatism produced by pterygium 
2) Threat of visual axis involvement 
3) Pterygium induced break up of tear film 
4) Severe symptoms of Ocular irritation 
5) Unresponsiveness to medical management 
6) Ocular motility restriction 
7) Binocular diplopia  
8) Cosmetic  
9) Leastly before corneal refractive procedures and cataract 
surgery. 
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ANAESTHESIA 
           For small pterygium topical or sub conjunctival block may be 
adequate especially for the bare sclera technique. A peribulbar or retro 
bulbar is preferred anaesthesia. This is necessary specifically for creation of 
conjunctival flaps, conjunctival autografting, amniotic membrane 
transplantation where careful dissection, control over the globe position, 
good hemostasis, closure with precise suturing. 
           A 7030 combination of 2% lignocaine with 0.75% of bupivacaine 
along with 1%apraclonidine pre operatively gives good conjunctival 
blanching. Also frequent instillation of 11000 adrenaline or 2.5% of 
phenylephrine aids in good hemostasis. 
EXCISION OF PTERYGIUM  
1) Historically surgical attempts were made towards redirection of 
pterygium‟s head away from cornea into either of the fornix. 
Modern technique is to excise the pterygium. 
2) Pterygium can be marked with a surgical marking pen, gentian 
violet, or Castroviejo callipers. 
3) The minimal area of the body of the pterygium should be 
marked since the excision of the advancing head gives a 
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relaxing effect on the conjunctiva which seemingly increases 
the area of the pterygium to be removed.                              
4) Various techniques are adopted by different surgeons. The 
following are the methods to remove the apex of the pterygium 
from cornea 
a) Avulsion of the head using a pair of forceps, using 
scissors underneath then shearing the head off the cornea. 
b) Dissecting with a sharp rounded blade. 
c) Dislodging the head by a sawing motion with the help of 
suture   
     5)       A centripetal approach is better. 
      6)  Casterveijo recommended a simple way of superficial 
keratectomy with care in not thinning the cornea. 
7) Most of the surgeons prefer to start at the apex, excision of the 
soft tissue of pterygium alone is done 
    8)   Lift up the tissue using forceps to achieve adequate plane of 
dissection. 
50 
 
   9)   Head neck body is removed as one piece by severing the 
attachment to the cornea using a surgical blade. And the body 
and base with Westcott scissors 
 10)  A sub conjunctival balanced salt solution can be used to balloon 
the conjunctiva  for easier dissection 
11) Hemostasis can be achieved with wet field cautery. 
12)  Smoothening of cornea limbus and sclera can be achieved by 
polishing with diamond  dusted burr. 
13)  Meticulous care should be taken not to damage the rectus 
muscle while cleaning up near the adjacent tissue. 
VISUAL AXIS INVOLVEMENT  
Precautions 
- Better to treat before visual axis involvement. 
- Routine avulsion with a modest amount of traction on the pterygium 
for disinsertion from the Bowman‟s membrane with a blunt dissection 
and scraping may produce a deeper cleavge plane in an already thin 
cornea, producing less than a quarter of thickness of the normal 
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stroma. This may even lead to a sight threatening descematocele that 
may require a tectonic corneal graft. 
- It is better to dissect the pterygium horizontally and proceed. 
- In case of corneal thinning it is better to do lamellar keratoplasty with 
a better outcome hopefully. 
BARE SCLERA TECHNIQUE 
                               After completion of the pterygium excision the 
conjunctival edges retract leaving behind a bare sclera of slightly sized 
bigger defect than the size of the excised pterygium. It is basically a 
simplest surgical method in pterygium treatment.  
                        The principle behind leaving a bare sclera is the conjunctival stem 
cells will migrate over the area of defective bare sclera. It is the quickest 
possible technique so far available with an absurdly high rate of recurrence.  
                        The recurrence rate is as high as ranging from 30% to 90% which 
is its greatest disadvantage and more frustrating for both the patient and the 
doctor. This was proposed by Mac Garis and O‟mbrien. 
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ADJUNCTIVE THERAPY 
                In view of the above major side effect following a bare sclera 
technique many    adjunctive therapy were tried. The adjunctive measures 
were in the form of medical methods,  radiation, and surgical methods were 
adopted in view of preventing the recurrence which was the most common 
and distressing consequence when attempted for a surgical relief of 
pterygium.  
RADIATION THERAPY 
               In the beginning variable amounts of irradiation which was not 
standardised properly was used with Grenz rays, radon bulbs, x-rays, radium 
plaques. Later it beta irradiation was found to be most effective and safest 
method of radiation. 
ROLE OF BETA IRRADIATION 
              Beta irradiation causes radiation induced ionisation changes in the 
cells involving its nucleus and cytoplasm. 
              The fibro vascular tissue with neovascularisation and fibroblasts in 
their peak periods of mitotic activity, division, proliferation which are radio 
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biologically and physiologically and which are responsible for pterygium 
recurrence are most susceptible. 
                It induces obliterative end arteritis. 
                The irradiation therapy has effect only on the immature tissue. 
REGIMEN 
    1) Beta irradiation using single application 
    2) Many number of application over days in the immediate 
post operative period 
     3) Over 2 weeks period several application. 
TECHNIQUE 
                      The distinct advantage of Strontium 90 applicator is it delivers 
irradiation in a DEPTH DOSE PATTERN. The active surface of the Sr 90 
applicator also delivers only beta emission and not gamma radiation. A 
standard Sr 90 applicator with a shield usually delivers approximately 3000 
reps (roentgen equivalent physical) per minute.1 rep = 1.08 rad. 
                      Beta irradiation spends their energy in a depth dose pattern. 
The applicator expends their maximum energy in the 2mm superficial tissue. 
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Then onwards the dose falls to 41% at 1mm depth, 19% at 2 mm depth, 9% 
at 3mm depth, 1% at 5 mm depth. More recently the suggested protocol is a 
dose between 1000 to 3000 rad either as a single intra operative application 
or fractionated dose over weeks.                  
             The recommended methodology for a better outcome in terms 
of inhibiting neovascularisation and fibrous proliferation is immediate 
application of beta radiation after surgical excision of pterygium. The 
technical problem is that experts for radiation should be available. 
                      The standard protocol followed is Sr90 brachytherapy with an 
epibulbar plaque. This has a central radioactive disc surrounded by a non 
active rim about 2mm. The dose delivered is in the range of 5 – 20 Gy/min. 
Total dose delivered will be in the range of 25 – 60 Gy in a 1 – 6 fraction.  
Antibiotics should be given post radiation together with corticosteroids. 
DISADVANTAGES 
Cumbersome instrumentation 
Recurrence of 16 % to 25% 
Beta irradiation induced cataract 
Chronic conjunctival hyperaemia 
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Keratitis sicca / iritis / episcleritis 
Corneal thinning / perforation 
Symblepheron / ptosis 
Scleral ulceration / atrophy / necrosis /  
Pseudomonas endophthalmitis 
CHEMOTHERAPY 
THIOTEPA 
                   It is nitrogen mustard group of drug. Chemically it is 
triethylenethiophosphoramide. Also it is a radiomimetic, alkylating drug. It 
hinders with the rapidly proliferating tissue‟s mitotic phase. This action is 
brought about by the release of ethylenimine radicals which exerts their 
action on the actively dividing cells.  
                 Thus its topical use prevents the capillary endothelial proliferation 
and there by pterygium. Thiotepa is commonly used at a dilution of 12000 or 
15000. Following a bare sclera excision of pterygium the drug is 
administered topically every 3 hours for the next 6 to 8 weeks. 
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COMPLICATIONS 
Irreversible poliosis 
Skin depigmentation. 
Allergic reactions 
Conjunctival pigment deposition / chronic conjunctivitis 
Scleral ulceration. 
MITOMYCIN „C‟ AS ADJUNCTIVE 
                   Mitomycin C is isolated from the Streptomyces caespitosus by 
its fermentation filtrate. It is basically anti biotic which also has anti 
neoplastic and anti metabolite property. Its greatest anti proliferative effect is 
preferentially on the cells that are rapidly dividing. 
                    Mitomycin C inhibits the DNA replication selectively and adds 
to the cellular RNA synthesis inhibition and protein synthesis. The 
fibroblasts normally produces collagen which is inhibited by Mitomycin C 
thus helps in preventing pterygium recurrence. 
                     Kunimoto and Mori of Japan were the first to describe the 
usage of Mitomycin C in pterygium surgery. Like glaucoma filtering surgery 
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in pterygium surgery it helps in decreasing the fibro vascular regrowth and 
scarring by inhibiting the episcleral fibroblast growth. Hence it is a bio 
reductive alkylating agent.  
USES OF MITOMYCIN C 
              Mitomycin C was used originally in the treatment of gastric and 
pancreatic carcinoma as chemotherapeutic agents.   
             It is used in selective ophthalmic procedures like  
1. Glaucoma filtering procedures for a longer bleb survival 
2. In treating corneal and conjunctival intra epithelial neoplasia. 
3. As wound healing modulator in Photo refractive keratectomy 
4. Adjunct in ocular cicatricial phemphigoid 
5. In nasolacrimal duct probing / nasolacrimal duct obstruction 
6. Silicone nasolacrimal intubation / dacryocystorhinostomy 
 HOW TO PREPARE IT? 
        Mitomycin C is available in market as a purple coloured powder. It is a 
2 mg or 10 mg vial. It should be freshly reconstituted with either distilled 
water or normal saline to attain a concentration of 0.2 – 0.5 mg / ml. To 
achieve this 10 ml of distilled to the 2 mg vial to be added and shaken well. 
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The reconstituted fluid now becomes light purple colour. If the final colour 
is not purple then it indicates the ineffectiveness of the drug. Such drug 
should be discarded. The final concentration is 0.2 mg / ml , which can be 
used on that day for many surgeries. 
METHODS OF APPLICATION 
            There are three methods of application. They are 
             1) Preoperative intra lesional injection 
             2) Intraoperative application 
             3) Postoperative topical application 
                    Of all these methods the currently used methods are 
Intraoperative and postoperative application.   
PREOPERATIVE INTRALESIONAL MITOMYCIN C INJECTION 
                     At least a month before the planned surgical excision this 
therapy is done. Routinely Mitomycin C is injected in to the head of 
pterygium. A single injection of 0.01% (0.1 mg / ml) of about 0.1 to 0.15 ml 
is injected in an attempt to destroy fibroblast. This helps in preparing the 
area recurrence free. Following a period of one month surgery was done. 
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                    Though the recurrence was grossly reduced this method 
demonstrated serious side effects. The minimum advantage due to this 
procedure was prevention of corneal epithelial damage due to the topical 
application and the low recurrence rate even with bare sclera technique. 
INTRAOPERATIVE MITOMYCIN „C‟ APPLICATION 
                           This was developed to decrease ocular morbidity and for 
such patients who are non compliant. This procedure makes many surgeons 
comfortable because of Mitomycin C use introperatively in glaucoma 
filtering surgeries. The results of this method are conflicting as there is no 
clear single protocol. Although the protocols differ it is an effective method. 
                      Many of the studies have quoted introperative application of 
Mitomycin C of 0.02% to 0.05% usage. Application of 0.2 mg/ml or 0.4 
mg/ml 2 to 5 minutes resulted fewer than 10% and 20% for primary and 
recurrent pterygium respectively. One of the study over period of 12 to 28 
month follow up showed no recurrence when Mitomycin C was applied 
intraoperatively at a concentration of 0.5 mg/ml along with subconjunctival 
20 mg depot steroid injection. 
                       The commonest dosage used is 0.02% applied for 3 minutes. 
Though a 3 minute application is less effective than a 5 minute application, 
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increasing the concentration and duration leads to higher risks of 
complication. 
COMPLICATIONS 
1) Corneal thinning / punctate Keratitis 
2) SCLERAL melting / perforation 
3) Scleral necrosis / scleritis 
4) Endophthalmitis 
5) Pain 
POSTOPERATIVE TOPICAL MITOMYCIN APPLICATION 
                   The commonest concentration of Mitomycin C postoperatively 
is 0.4 to 0.2 mg/ml which is applied topically 2 to 4 times a day for a period 
of4 days to 2 weeks after surgery. The recurrence rate of this adjunctive 
therapy with an excisional surgery was around 2.4% in a study by singh et 
al. Comparing the recurrence rate of 25% in a conjunctival autograft group 
with Mitomycin C drop of 0.2 mg/ml as b.i.d application for 5 days the 
results were exuberant around 9.4%. 
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ADVANTAGE 
Better than radiation therapy 
Results were comparable with conjunctival auto grafting 
Safer method 
COMPLICATIONS 
1) Wound dehiscence 
2) Corneal edema 
3) Corneal ulceration / perforation 
4) Secondary glaucoma 
5) Iritis 
6) Scleral ulceration / necrotising scleritis 
7) Scleral calcification 
8) Pain  
 9) Sudden onset mature cataract 
10) Misuse / prolonged application leading to greater incidence of 
the above 
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CONTRAINDICATION 
1) Dry eye 
2) Atopic kerato conjunctivitis 
3) Herpes keratitis 
5- FLUROURACIL 
                    Anti fibrotic agent, this inhibits DNA synthesis. There are only 
few studies related to this drug. All employed intraoperative 5- flurouracil of 
10 mg/ml for 5 min. The results of the few studies have warranted further 
investigation in to its role. 
OTHER ADJUNCTS 
                    Dauxorubicin 0.02% for 3 minutes, cyclosporine 1% as eye 
drops, thiotepa 0.05% eye drops, daunorubicin 0.02% are other promising 
medical adjuncts. Also sub- conjunctival anti-VEGF Bevacizumab 1.25 to 2 
mg is also under trial. 
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AMNIOTIC MEMBRANE TRANSPLANTATION 
History 
                    The first documentation of amniotic membrane in clinical 
medicine was that of Davis. He used both amnion and chorion for skin 
transplantation. In 1940 it was De Roth and in 1946 Sorsby and Symons 
were the first to use it in the treatment of conjunctival defects and 
reconstruction of ocular surface. 
                     In those days processing and preservation of the tissue was not 
easy and it made its availability limited. Kim and Tseng in 1995 introduced 
with better tissue techniques in to ophthalmology.  
PREPARATION AND STORAGE OF AMNIOTIC MEMBRANE 
                     Placentas are obtained from donors who undergo elective 
LSCS. This is because vaginal delivery may cause contamination. The donor 
should have been screened for human immune deficiency virus, hepatitis B, 
hepatitis C, HTLV-1 & 2, syphilis before placenta harvestation and 6 months 
later also.  
                   The placenta obtained is separated from chorion by blunt 
dissection. And then it is washed in antibiotic containing physiological 
64 
 
saline. Or is subjected to lamellar flow hood where it is cleaned of its blood 
clots using sterile Earle‟s balanced saline solution containing penicillin and 
streptomycin of 50 microgram/ml, 100 microgram/ml of neomycin and 2.5 
microgram/ml of amphotericin.  
                   The separated amnion is then placed onto nitrocellulose paper of 
size 0.45 micrometre. It is placed with epithelium side up. Amnion over the 
nitrocellulose paper is now cut into pieces of 4*4 cm size. STORAGE is 
usually in a 11 ratio of Dulbecco‟s modified Eagle medium and glycerol at – 
80 deg C. 
                  Other commercially available preserved amnion is sterile low 
heat dehydrated and cryopreserved. The former can be stored at room 
temperature and rehydrated with saline solution whereas the latter is stored 
at -80 deg C with 50% glycerol with the epithelium side up which should be 
thawed before its use.   
                   This epithelium should be differentiated from the stromal side by 
touching with a Weck-cell sponge. The sticky side is the epithelium side. 
The epithelial cells that are cryopreserved show the presence of 
approximately 50% of epithelial cells to be VIABLE and continue 
production of cytokines. 
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LAYERS OF AMNION 
                    Inner most layer of placenta is AMNION. This has 5 layers. 
They include  
                     1) A single layer of epithelium 
                     2) A basement membrane 
                     3) Avascular connective tissue layer – which is of 3 layers 
                             a) A compact layer attached over basement membrane 
                             b) The fibroblast layer 
                             c) The spongy layer 
                    The amnion is around 0.02 to 0.50 mm thick. Of all the layers 
the Strongest is compact layer, which gives a significant amount of tensile 
strength. The thickest layer is the layer of fibroblast. It is of reticulum and a 
loose fibroblast network. The outer most layer of amnion – the spongy layer. 
MECHANISM OF ACTION 
                   Though the mechanism is not fully understood the biological 
factors like cytokines and collagen is the difference an amniotic membrane 
makes from the bandage soft contact lens. 
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- Growing evidences suggest amniotic membrane provide a 
superior substrate for migration of epithelial cells 
- Promote differentiation of epithelial cells 
- Helps in attachment of basal epithelial cells 
- Prevents apoptosis of epithelial cells 
- Helps in decrease of inflammatory cell infiltrate thereby reduce 
fibrosis and neovascularisation. 
BACKGROUND SCIENCE 
1) Anti inflammatory  
2) Anti fibrosis 
3) Anti angiogenesis 
4) Anti apoptotic  
                     Basically due to the presence of type 4 collagen and laminin in 
the amniotic basement membrane it resembles close to the composition of 
conjunctival basement membrane than that of cornea. In addition it also has 
collagen type 3. 
                     The expression of cytokines in amniotic membrane was 
recently evidenced. Though the epithelium and stromal layer expresses the 
cytokines it is predominantly synthesised by the epithelium. This cytokines 
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helps the amniotic membrane to decrease the inflammation scarring and 
lastly neovascularisation. 
                      Amniotic membrane also has nerve growth factor, keratocyte 
growth factor, and epidermal growth factor serving a role in epithelialisation 
of the ocular surface after amniotic membrane graft. 
                      Amniotic membrane also specifically suppresses signalling of 
the transforming growth factor beta leading to a reduction in fibroblast and 
the scarring.  
                       AMG epithelial cells express interleukin-1 receptor antagonist 
matrix metalloproteinase inhibitors – 4 type‟s interleukin-10, 
thrombospondin-1 which is all potent anti angiogenic agents. Also AMG 
traps the apoptotic inflammatory cells like monocyte macrophage lineage. 
                    The most interesting part of the amniotic membrane 
transplantation unlike other allograft transplantation is it doesn‟t require 
immunosuppressive therapy because the graft membrane typically gets 
dissolved within a period of 3 to 5 weeks. 
                   Though amnion is supposed to be an immune privileged tissue, 
all the parts of it contain HLA class 1 and 2 antigens the amnion does have 
enough strength to suppress alloreactive T cells in vitro. 
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                   The most surprising and required property of amnion is it 
supports original phenotype of a non goblet conjunctiva in vitro but AMT 
helps maintaining normal goblet cell differentiated conjunctival epithelium. 
This gives the advantage of its superiority over other grafts like buccal, 
mucous membrane. 
TECHNIQUES 
                   Amniotic membrane can be used as 1) graft 2) protective patch. 
To secure the said function the graft orientation alone differs. A graft helps 
primarily in epithelial regeneration. 
 
            1) OVERLAY TECHNIQUE 
                   The amniotic membrane is kept epithelium side down. 
            2) INLAY TECHNIQUE 
                    The amniotic membrane is kept epithelium side up i.e. basement 
membrane down. This can be laid as in 1 or multiple layers depending on the 
stromal defect. An overlay can be preceded over an inlay according to the 
surgeon‟s discretion. 
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SURGICAL PROCEDURE 
LOCAL ANAESTHESIA- a retrobulbar or a peribulbar block to be given 
with a facial block. 
                  Along the diseased surface the conjunctiva is incised 
horizontally. If Tenon‟s fascia is healthy the conjunctiva is undermined from 
it, so that the healthy Tenon‟s fascia gets retracted to its normal anatomy. 
Abnormal diseased tissue should be dissected if around the muscle sheath. 
                  Corneal involvement if present should be removed this may help 
in better graft taking up. A cryopreserved graft has to be thawed before 
usage. A low-heat-dehydrated graft minutes before application should be 
rehydrated with saline. 
                 A graft approximately 20% larger than the conjunctival or the 
corneal defect should be measured and taken. It should of sufficient amount 
that it should cover the required area without any tension or stretch.                               
                   Staining of AMG can be done with Lissamine green B 1% dye 
before removing it from the nitrocellulose paper for better visualisation the 
edges folds and for proper orientation during surgery. It is not toxic to 
cornea and the colour fades away with returning of normal colour of 
amniotic membrane within the next 120 minutes. 
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                  Depending on the technique overlay/inlay the graft is placed and 
is secured with 8-0 vicryl suture to the conjunctival edge along with the 
episcleral tissue it. Episcleral incorporation is important in that it helps in the 
patch or graft retraction.       
                  Antibiotic ointment and a pressure bandage can be applied. 
Sutures can be removed weeks later. 
                  The recurrence of pterygium depends on the incompletely 
dissected sub conjunctival tissue and the residual Tenon‟s fascia. 
ADVANTAGES 
1. It can be substituted in place where large graft is required. 
2. Avoids iatrogenic damage to the normal conjunctiva which    
should be donated. 
3. It is technically easier and faster. 
4. It has wide range of recurrence rate and is higher than that of  
autografts. 
5. AMG along with Limbal or conjunctival auto graft is more 
successful. 
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DISADVANTAGE 
1. Delayed vascularisation leading to recurrence. 
2. Higher recurrence rate than auto graft. 
3. Risk of infection. 
CONJUNCTIVAL FLAP 
                      Conjunctival flap concept was first introduced by Schoeler. 
Further Khunt made it popular. To help retard infection in cataract surgery 
conjunctival placement was done by Van Lint. Purse string flap and Hood 
flaps were described. Purse string flap retracted faster months before hood 
type. Gunderson was the one who described the technique of conjunctival 
flap which is used even today. 
                        He designed a thin flap by dissecting underlying Tenon‟s 
fascia which remains a success even today. His technique is successful even 
today for the fact that because of the removal of the Tenon‟s fascia the 
flap showed reducedcontractility. There by allowing a permanent coverage 
of the diseased area. 
                     The different type of flaps is Total flap, Partial flap, Racquet 
flap, Bucket handle flaps. The partial advancement flaps offer advantage of 
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intra ocular pressure measurement, better visualisation anterior chamber, 
with short fornices.  
                      Bucket handle flaps offer a rich vascularised bed. Recently 
Khodadust and Quinter used thick partial flaps with Tenon‟s capsule 
successfully deeper corneal ulceration. 
                    The mechanism of success is not known exactly. These flaps 
relieve eye pain. Refractory ulcers and necrotic areas forms scar with flap 
placement. Thin flaps provide vascular membrane helping with blood 
factors. They also play a role providing fibroblasts. 
                   For decades conjunctival flaps were used in the treatment of 
pterygium surgery. The technique most commonly used are sliding, pedicle 
type flaps and rotation flaps. The normal conjunctiva when body of the 
pterygium is rotated to bulbar conjunctiva, is taken to Limbal part is called 
conjunctival „Z‟ plasty.  
                 The conjunctiva if harvested from inferior or superior bulbar 
conjunctiva to close the bare sclera, it is called as sliding conjunctival 
flaps. The recurrence rate of the various techniques ranged from 1-5%. 
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DISADVANTAGES  
1. Visual impairment 
2. Impaired view of anterior chamber 
COMPLICATIONS 
1. Button hole 
2. Flap retraction 
3. Epithelial cyst formation. 
4. Post operative ptosis 0f 1-3mm. 
5. Erosions of the flap. 
6. Recurrence. 
CONJUNCTIVAL GRAFTS 
                  The procedure of autologous conjunctival graft use in the ocular 
surface reconstruction was first done by Thoft. Conjunctival auto graft is 
presently used as the procedure of choice in both primary and recurrent 
pterygium surgery. 
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                 In 1985, Kenyon et al introduced the basic technique of 
conjunctival auto graft. Autologous grafting procedure covers a wide variety 
of diseased ocular surface treatments like ocular surface tumours, chemical 
injuries, cicatricialentropion and plastic construction of lid. 
ADVANTAGES 
1. Relative low recurrence rate. 
2. Absence of life threatening complications. 
3. Normal anatomic supplement. 
4. Cosmetically better. 
5. Undergoes a natural repair process. 
6. More efficacious. 
7. Long durability and safety. 
DISADVANTAGES 
1. Skill and experience is required 
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`BASIS FOR USING CONJUNCTIVA AS GRAFT 
                     This technique provides a normal conjunctival mucous 
membrane with a superficial vascular network and other cells providing 
stem cells, columnar surface and the normal goblet cells. Following grafting 
the normal cells of the conjunctival surface spread over abnormal surface. 
This migration of cells can be seen and can be outlined by its patterns with 
use of flourescein. The abnormal cells can be tracked by Rose Bengal stain.  
                      The advantage of conjunctival auto graft over mucous 
membrane grafting is very minimal graft shrinkage also a normal reparative 
process with secondary intention closure. Thin conjunctival flaps allow 
faster revascularisation and also eliminate sub epithelial fibrosis and 
shrinking of the graft. Thus decreases the inflammatory and scarring 
stimulus. It is real when it is said the best cosmesis is obtained with the 
conjunctival graft procedure, also the lowest recurrence rate. 
 
METHODS 
                    The following are to be measured before obtaining the graft for 
more precision –  
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        1) Width at the limbus. 
        2) Width of the nasal lesion. 
        3) Limbus – nasal margin distance. 
SURGICAL CONSIDERATIONS 
                    In mild cases simple conventional techniques like conjunctival 
Z plasty is used. In cases of severe tissue destruction and advanced scarring 
a free conjunctival mucous membrane graft are used. Before attempting any 
kind of procedure the presence of inflammation and necrosis has to be 
treated, because neglect in this part may lead to unsatisfactory result like 
failure of graft. But in cases like progressive disease due to a lack of 
adequate stem cells has to be intervened early. 
AUTOLOGOUS CONJUNCTIVAL  TRANSPLANTATION 
                      A successful result with grafting per se is with a careful and 
complete separation and excision of the diseased part of conjunctiva here 
especially pterygium. It is important both to preserve as much conjunctiva as 
possible at the same time to remove as much possible as sub epithelial 
fibrosis. 
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                    In desperate situations where a sufficient amount of graft is not 
available to meet a demand like a larger area, patches of graft usually small 
in size in the most critical parts especially around the corneal limbus can be 
used with hope. When patches of graft tissue is used the cells transplanted 
starts migrating and filling up the defects. The adequate Maintenance of the 
fornices is also important.  
                     The first step is graft site preparation. Maximum possible 
resection of the scar tissue and recipient site bleeding should be under 
control. Next thing to be done is measurement of the recipient bed size so 
that donor graft requirement can be established.  
                     The excessive thickened Tenon‟s capsule to be removed. This 
is important in debulking the recipient bed there by allowing an enhanced 
adherence and acceptance of the graft. Only this gives a better cosmesis and 
functional outcome. 
                     The usual site of conjunctival auto graft is from supero 
temporal region either ipsilaterally or from contra lateral eye. As the donor 
site is in an oblique location inadvertent injury to the extra ocular muscle can 
be avoided. Also since it is behind the upper lid it is better for the patient as 
it is more comfortable. And healing at this site is better. A 7-0 silk is sutured 
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at the limbus supero temporally. This helps in the downward and inward 
displacement of the eye there by exposing the supero temporal part of the 
conjunctiva. 
                   The auto graft harvest site is marked with surgical ink, surgical 
marking pen or with the help of gentle bipolar cautery as four quadrants. 1% 
lignocaine with 1/ 100000 adrenaline is injected sub conjunctivally with a 30 
gauge needle. This helps in the separation of Tenon‟s fascia from the surface 
mucous membrane. 
                   Nasal and temporal margins of the harvest site are superficially 
incised carefully using a crescent knife placed vertically. Now the Limbal 
and the Forniceal margin are the fixation points for its dissection. With the 
help of a Westcott scissors or Vanas the Tenon‟s is separated. Now the 
Forniceal margin is cut and reflected over cornea. 
                    Most importantly the conjunctiva alone should be excised 
completely separating it from Tenon‟s capsule, so that the graft stretches 
more easily over the defect made. This provides a good tissue apposition, 
also allowing conjunctiva to stretch easy covering of the wound and faster 
healing of the auto graft site too. 
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                      Important advantage of the complete separation of the graft 
tissue from its surrounding structure is it prevents graft retraction and graft 
oedema, which will be the immediate post operative complication leading to 
failure of graft. 
                       Care should also be taken not to button hole the flap. Forceps 
use in handling the graft is to be avoided. So for retraction of the flap 
surgical spear or non toothed forceps can be used. Excessive manipulation of 
conjunctival flap is to be avoided. Strictly speaking a minimal touch 
technique is to be adhered to.  
                       After laying the flap over the defect press it over the cornea so 
that sub epithelial fibers over the sclera becomes taut. Finally the anterior 
Limbal border can be cut, with or without including the Limbal palisades of 
Vogt. At the limbus dissection should be parallel to it. NO IRRIGATION 
TO BE USED UNTIL ATERIOR CARDINAL SUTURE PLACEMENT. 
                    The donated site is not closed. It is left bare. Over years of 
experience it is seen that bare area created get re epithelialised without 
shrinkage. A second thought is the donor site can be closed with 10-0 nylon 
suture. So far COMPLICATION ARE NOT NOTED AT THE DONOR 
SITE.  
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                   The graft with great care is taken to the recipient site without 
eversion. Maintaining proper orientation of graft is very important while it is 
transferred to the recipient site. The basic technique used here is it is slid 
over cornea followed with limbus to limbus orientation, and with a draping 
motion is flipped over so that the epithelial side is up. 
                     Routinely the graft is sutured in the Limbal ends first – the 
cardinal sutures. A 10-0 nylon suture material is used. While taking a bite 
the episcleral tissue has to be included within. Multiple equidistant 
interrupted sutures are done. 8-0 chromic collagen nolonger available was 
used before. 8-0 , 9-0 monofilament polyglactin sutures can be used but 
superior is monofilament nylon. 
                      Necrosis around suture and irritation makes the polyglactin as 
not an ideal choice. After suturing the sutures are cut a little longer allowing 
movement while blinking, comfort also easier while removing. Application 
of a double patch at the end of the procedure is mandatory. 
                      Post operatively 4 times daily an antibiotic – steroid drop is 
applied. And then tapering over a month is done. Artificial tears and 
lubricating gels are used sufficiently. Sutures are usually removed at 2 
weeks post operatively. A low dose mitomycin of 0.2 mg can reduce forther 
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recurrence. For the first 3 – 5 days post operatively the graft appears 
toedematous and avascular. Up to the next 2 weeks the graft becomes 
vascularised, hemorrhagic and even edematous. Adherence of the graft 
occurs in 7 – 10 days. Within a couple of months the graft gives a normal 
appearance. 
VARIATIONS; 
                     These are the variations from the routine conjunctival autograft.  
 Narrow strip (juxta Limbal) of the graft 
 Limbal epithelial auto graft 
 Limbal conjunctival auto graft 
 Rotational conjunctival auto graft 
COMPLICATIONS / DISADVANTAGE 
 Time consuming 
 RECURRENCE – ranges between 2 to 39% 
 Meticulous procedure – needs experienced surgeons. 
SUCCESSFUL GRAFTING 
1. Atleast 1mm bigger sized graft. 
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2. Complete removal of pterygeal cells. 
3.  Tenon free graft 
4. Perfect graft stabilisation. 
CONJUNCTIVAL ROTATION AUTOGRAFTING 
                     In cases of extensive pterygium, where extensive area is 
excised and left bares this is a better choice of covering the defect.  
Usually in such a situation a desirable amount of donor tissue can‟t be 
obtained from the supero temporal part.  
In such cases removal of the diseased part followed by reversal of the 
removed conjunctiva is done such that the limbus is sutured with the nasal 
aspect and vice versa. 
PERFECT – pterygium extended removal followed by extended 
conjunctival transplantation. Hirst et al described the procedure. The method 
is about 15 mm / 12 mm bare scleral area is created which is covered by a 
graft of similar size. 
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CONJUNCTIVAL ROTATIONAL AUTOGRAFT 
Step 1 
 
Step 2 
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PERFECT 
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  Principle is conjunctival Tenon‟s excision is done which is large. This large 
graft is said to yield a good healing and a better cosmetic appearance. 
ALTERNATIVE PROCEDURES 
                   When in situations where sufficient amount of conjunctival 
grafting is not possible the other possibilities are usage oral mucous 
membrane, rarely labial mucous membrane. There is no vascularisation. 
Only if there is a mode of vascularisation for the graft is available it will 
survive, otherwise lead to unsightly cosmetic appearance.             
                 Epithelium of oral mucosa is a non keratinised epithelium. The 
oral mucosal cells when cultivated resemble corneal epithelial cells. The 
technique of cultivation can be feeder free or a feeder cell on HAM or 
temperature responsive gel as substrate. 
DISADVANTAGES 
1. Surgical procurement of the tissue is more cumbersome 
 2. Shrinkage of graft. 
3. Doesn‟t help in cellular transformation 
4. Tear film physiology is altered which is unacceptable 
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LIMBAL AND LIMBAL CONJUNCTIVAL TRANSPLANTATION 
                      A recent etiopathogenesis that is formulated in the formation 
of pterygium is Limbal stem cell anomalies. Hence on using the Limbal 
tissue containing stem cells it may hinder the migration of the conjunctival 
cells over the cornea and helps in the prevention of recurrence of the disease. 
STEPS 
1. About 0.5 mm from limbus a circular incision is made of 100 to 
150 mirometer depth on the cornea. 
2. Usual size of graft not exceeding 6 mm. 
3. Along with the conjunctival graft 0.5 mm of peripheral cornea to 
be included. 
4. Conjunctival side should be sutured with 10/0 absorbable 
material  
5. The corneal side to be sutured with 10/0 nylon interrupted 
sutures 
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ADVANTAGE 
Recurrence is 0 – 15% 
More effective 
DISADVANTAGE 
Technically more demanding 
Time consuming 
No support of conclusive evidence 
Graft harvesting at Limbal site itself damages 
CULTIVATED CONJUNCTIVAL TRANSLANTATION 
                     It is a method of ex – vivo expansion of the conjunctival 
epithelium on a substrate like amniotic membrane usually. The amniotic 
membrane which is intact helps in retaining the stem cell characteristics and 
also promotes growth. The cells that are grown on the membrane are 
explanted and now are nourished with 3 – 4 ml of medium. Then it is 
incubated with 5% CO2 at 37degree.  
                    When a single layer of cells from the explants becomes 
confluent in 10 – 14 days the Culture is terminated. 
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                    On using this cultivated conjunctival transplantation the ocular 
surface gets re-epithelialisation almost immediately, thus reducing post 
operative inflammation, there by achieving rehabilitation faster. This method 
is useful in closing extensive defects after a pterygium surgery. 
TISSUE ADHESIVES 
                     Refojo et al and Webster et al were the first to report the usage 
of tissue adhesives in ocular surgery as a part of management of corneal 
perforations. All tissue adhesives available are considered as off – label 
application. 
USES OF TISSUE ADHESIVES 
Used in tissue scaffolding 
Structural fillers 
As an additive to sutures 
ADVANTAGES 
Easy availability 
Easier and faster application 
Cost effective 
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Decrease the operating time 
Decreases pain and the surgical risk 
TYPES OF TISSUE ADHESIVES 
1. Cyanoacrylates 
2. Fibrin glue 
3. Marine glue 
4. Others 
Cyanoacrylates 
                     They are rapid polymerizing compound. They tend to 
polymerise as soon as it comes in contact with some fluids such as water, 
blood. During the process of polymerisation bonding to the tissues to which 
it is applied occurs.  
Mechanism of action 
                     In an ulcer treatment they do not provide structural support as it 
covers the area. Instead it stops the ongoing process of proteoglycan and 
collagen degradation by eliminating its presence from the ulcerating area. 
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                   Cyanoacrylates were used in dermatologic and dental 
application. The available agents are methyl 2 – cyanoacrylate others are n – 
butyl, n – heptyl, octyl derivatives. Under exothermic conditions they 
rapidly polymerize forming at the end solid polymers. 
STEPS 
1. Isocyanate reacts with water forming carbamic acid. 
2. Formed carbamic acid decomposes rapidly to carbon –   
dioxide along with its amine. 
3. The formed amine reacts with the available isocyanates thus 
cross linking the adhesives. 
Two methods are used in the application of adhesive  
1. Drop method  
2. Disk method 
HUMAN FIBRIN ADHESIVE 
                    They are bio degradable. Used beneath a biological surface. 
They form non toxic metabolites helps in faster re epithelialisation. The first 
use of these fibrin based adhesives was for hemostasis. It was first 
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introduced as a bovine derived product. This bovine aprotinin is antigenic 
which may result in serious reaction. Later the technique utilised human 
derived thrombin with aprotinin which helps in retardation of fibrin clot lysis 
there by improving allergic tolerance too. 
                   The adhesives are greatly used in general and vascular surgery 
fields. The commercially available preparation is Tisseel VH Fibrin sealant. 
It has off – label application in ophthalmology. 
Mechanism of action 
                   It has thrombin and fibrinogen derived from pooled human 
plasma. This fibrin glue is also prepared from autologous blood, usually a 
cryoprecipitate method which harvests fibrinogen. 
                  Tisseel VH gives a firm, clear, gelatinous clot of fibrin. It is 
formed of fibrinogen, plasminogen, and factor 8, fibronectin from human 
pooled plasma with bovine aprotinin solution and thrombin with calcium 
chloride there by initiating the final stage coagulation cascade. 
                 The time taken for both to react can be controlled changing the 
thrombin concentration (4 IU/ml to 500IU/ml). The strength of the reaction 
is 70% at 3 – 5 min and a maximum of 100% within hours.  
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                    At the end factor 8 with fibrin forms clot. This formed clot of 
fibrin should be left undisturbed for which the bovine aprotinin is added. 
This aprotinin – a fibrinolysis inhibitor protects against the degradation of 
clot.    
APPLICATION METHODS 
                     Tisseel kit mixes equal volumes of thrombin and fibrin 
solution. It has 2 syringes with plungers linked to it with one mixing hub 
(Duploject). So this is one method where equal volumes are mixed. The 
other method practised is each of the above said solution is applied 
separately in the opposing sides of the tissues to be adhered. 
                     Typically by 30 to 60 seconds achieves a better seal. Prior to 
applying glue the field should be dried. Routinely for 3 minutes gentle 
pressure is applied after glue application for better adhesion.  
                     It is used in many procedures like conjunctival flaps, grafts, 
amniotic membrane graft. After application gently stroke should be made 
with wet cellulose sponge. Minimal tension should be made while 
manipulation. Post operative application of aprotinin drops may be used as 
clot lysis inhibitor. Human fibrin adhesive stays in vivo for less than 2 
weeks. 
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DUPLO JECT INJECTOR 
 
 
 
ADVANTAGES 
It is an alternate for suture. 
Suture related complication minimised. 
Surgical time is reduced. 
Recurrence rate is low as 6%. 
It is better than cyanoacrylate. 
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DISADVANTAGES 
High cost. 
Risk of transmission of infection like HPV B19 is high. 
Graft displacement. 
Antigenic responses are anticipated. 
MARINE GLUE 
                    Certain marine species with their barnacles and mussels produce 
some adhesive substances like mussel adhesive protein from Mytilusedulis. 
Intra stromal injection with MAP at a dose of 5mg/ml was given and 
studied. It showed a less tissue reaction and better biologic glue. 
FUTURE OF OCULAR ADHESIVES 
                     Currently used human fibrin adhesives are modified; they are 
antibiotic and growth factors, recombinant proteins, stem cell infusions etc. 
Newer things under investigations are uronic acid compounds, poly (L-
lactic-co-glycolic acid) with laser activated serum albumin, riboflavin 
fibrinogen compound, biodendrimer compounds. 
 
95 
 
GLUELESS SUTURELESS GRAFT FIXATION 
                   The initial steps of pterygium excision are done. The 
conjunctival auto graft is prepared. In this newer technique blood clotting 
mechanism is exploited. Here as in other procedures like graft fixation with 
suture or fibrin adhesive, hemostasis is not allowed to occur with cautery.  
                   Instead the key mechanism of hemostasis is achieved 
spontaneously by body‟s own clotting mechanism. In reality the oozed out 
blood clot after pterygium excision itself acts as a tissue adhesive and graft 
fixation attained there by.   
                  This technique proper is about the involvement of coagulation 
cascade. It starts with the initiation of the extrinsic pathway passing through 
the common pathway which finally supplies the in vivo fibrin and thrombin 
needed for coagulation. 
                   After any vascular injury, body‟s hemostasis comes into play in 
controlling bleeding. Initially arteriolar vaso constriction due to reflex 
neurogenic activation occurs which is helped by the endothelium. 
                 Further thrombogenic extra cellular matrix of endothelium is 
activated, this brings about platelet adhesion. Aggregation of platelet along 
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with above mechanism forms the haemostatic plug. Also endothelium 
synthesises tissue factor a pro coagulant factor.  
                  This along with platelets activates in thrombin and coagulation 
cascade. The thrombin helps in formation of fibrin from circulatory 
fibrinogen. Thrombin itself recruits further platelet and granule release.  
                  Prime role in normal hemostasis is by platelets. It has 2 types of 
granules. They are alpha granules expressing P- selectin an adhesion 
molecule. And others like dense bodies. 
                  After a vascular injury like opening of the blood vessel like in the 
current situation where the small arterioles are intentionally cut extra cellular 
matrix are sequestered underneath an intact endothelium. Because of this 
further three reactions happens. They are 1) adhesion 2) secretion 3) 
aggregation. 
                   The final component of a normal hemostasis is coagulation 
cascade. It is a series of conversion of inactivated pro enzymes in to 
activated enzymes resulting in formation of thrombin. Thrombin converts 
soluble fibrinogen into insoluble fibrin which constitutes the common 
pathway of coagulation mechanism. Once this cascade is activate the 
clotting mechanism is restricted to the local site.  
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COAGULATION CASCADE 
 
 
 
 
 
      
                    With formation of primary clot, the donor conjunctival auto 
graft which is larger than that of the bare area is placed with carefully 
oriented limbus to limbus over the scleral bed with the epithelium side up in 
a draping motion and is gently pressed or tucked in for about three minutes 
with the help of Weck sponge cell and waited for seven minutes.  
                    The graft stabilisation is ensured for its firm adherence to the 
bed by testing centrally and each free edge. A thin graft which is spread 
smoothly usually gets adhered to the bed with the clot formed. The clot gets 
absorbed within a few days. This further enhances the collagen and thereby 
Pro thrombin  Thrombin  
Fibrin  
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the wound healing. The conjunctival stem cells also play a major role in the 
uptake of the graft.  
                   The natural inflammatory and fibroblast response gives rise to a 
more contractile healed bed if the scleral bed is left as such. In order to 
overcome the natural process of healing, fibrin glue like a tissel which by 
using the principle of doubling the clotting mechanism overwhelms the 
natural process of fibrosis and inflammation giving rise to a smooth and 
close to original ocular surface.  
                    Similar such results were obtained with auto blood graft 
fixation. It is superior to the fibrin glue in being autologous. Hence it is 
definitely disease free and free of allergic reactions. 
                   Towards the end of surgery donor site should have been closed 
by a single suture with 10-0 nylon. The lid speculum should be removed 
carefully.  
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SUMMARY OF PRIOR PUBLICATIONS 
                                         A prospective cross sectional study conducted on 15 eyes with 
sutureless glueless CAG after pterygium excision in 2008-09 in Belfast at 
mater hospital. Mean follow up time was 9 months. The mean surgical time 
was 14 min. No transplant dislocation or failures. No intra op post op 
complication noted. Also apposition of lids to bulbar conjunctiva provides a 
natural biological dressing conferring a unique wound healing environment. 
                                        In another prospective interventional case series 40 eyes in 2010 
underwent surgical excision of pterygium and suture less glue less CLAG 
fixation. To ensure consistency same surgeon performed all the surgeries. 
The mean follow up period was 9.2 months.post operatively mild chemosis 
was noted which disappeared by 7
th
 POD. Graft retraction in 3 eyes. And 
graft dehiscence in 2 eyes, but was due to trauma in 1 and accidental 
inclusion of Tenon‟ in the other. With a mean follow up of 9.2 months 
recurrence was seen in 1 patient. Hence it is a safe, effective, economical 
and cosmetically excellent method. 
                                         In another prospective case control study comparison was done 
between CAG fixated with fibrin glue and patients own blood as tissue 
adhesive. 20 patients were divided randomly into 10 each. Follow up was for 
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12 months. Duration of surgery was 14 min in group 1 and 17 min in group 
2. Though the rate of recurrence was equal in both, statistically insignificant 
difference in complication was noted. 
                     Another comparative prospective study in 124 gases was 
done between CAG with auto blood and electro coaptation. Mean 
surgical time was 10.6 min with auto blood and 8.3 min with electro 
coaptation. Follow up was for 4-21 months. 3 cases had recurrence. 
Both procedures had good and faster rehabilitation with good osmosis 
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PART TWO 
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STUDY PROPOSAL 
TITLE 
Prospective study on the efficacy of glue less, suture less 
conjunctival auto graft fixation in pterygium surgery. 
AIMS AND OBJECTIVES 
AIM 
This study is based on the evaluation of excellence in surgical 
and post surgical outcomes following sutureless, glueless pterygium 
surgery with conjunctival autograft.  
OBJECTIVES 
1) To study the efficacy of a glueless, sutureless auto graft   
fixation. 
2) To study in terms of intra operative timing for the procedure. 
          3) To study in terms of immediate post-operative graft 
dehiscence, pain, irritation and astigmatism. 
4) To determine long term complications like recurrence. 
5) To study in terms of cost effectiveness and for its cosmetic  
excellence. 
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DESIGN OF THE STUDY 
 Prospective  study. 
PERIOD OF STUDY 
6- 9 months. 
SAMPLE SIZE 
     40 patients 
ETHICAL CLEARANCE 
Letter of Approval obtained 
FINANCIAL SUPPORT 
Nil. 
MATERIALS AND METHODS  
           It includes all patients who will be presenting with 
primary pterygium fulfilling the inclusion and exclusion criteria 
attending OPD at Government Rajaji Hospital. 
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INCLUSION CRITERIA 
1) Patients with primary pterygium of both sex of 20 -50 
years age group. 
2) Patients with diminished vision due to astigmatism or 
encroachment on pupillary area. 
3)      Patients with progressive nasal pterygium. 
            4)     Patients with pterygium causing cosmetic disfigurement. 
            5)     Patients with pterygium causing persistent discomfort. 
            6)     Patients with pterygium causing restricted ocular mobility. 
EXCLUSION CRITERIA 
           1)      Patients with ocular surface diseases 
           2)      Patients with prior history of ocular surgery or trauma. 
           3)      Patients with pterygium with cystic degeneration. 
4)    Patients with Temporal / Recurrent / Atrophic Pterygium / 
Pseudo    Pterygium. 
5)      Patients with glaucoma. 
6)      Patients on anticoagulants. 
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METHODOLOGY 
                       40 Patients with primary pterygium who reported in 
ophthalmology department, GRH, Madurai were recruited in the study 
after obtaining informed consent. All patient data were collected and 
underwent comprehensive evaluation which included age, sex, ocular 
history and examination, assessment of visual acuity, keratometry, slit 
lamp bio microscopic examination. 
                       Patients with recurrent pterygium, patients with 
glaucoma and patients on anticoagulants, ocular surface disease were 
excluded from the study. Uncorrected Visual Acuity and Best 
Corrected Visual Acuity were assessed. The amount of astigmatism 
was noted before and after surgery. 
 
SCREENING 
                    All patients with pterygium underwent a detailed ocular surface 
examination to rule out tear film dysfunction. With + 90D and 
biomicroscopy fundus examination performed. 
                  Pterygium of every eye was morphologically graded and staged, 
according to Madrid‟s group system. The corneal invasion was measured 
appropriately using slit lamp biomicroscopy and graded. 
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GRADE  1  –  pterygium across limbus and a point midway 
between limbus and papillary margin. 
GRADE  2  –  growth upto papillary area. 
GRADE  3  –  growth crossing papillary axis. 
 
SURGICAL TECHNIQUE ADOPTED 
  All the pterygium surgeries were done under peribulbar 
anaesthesia. Strict asepsis was adhered throughout the procedure. 
Painting, draping followed with application of wire speculum was 
done. 
                 At the head a small incision is to be made, avoiding the 
abnormal part of conjunctiva. The conjunctiva was dissected from the 
pterygium along its body up to the fornices. Now the head of the 
pterygium using traction and blunt dissection is avulsed.  
               The body of the pterygium is now excised. The residual tissue 
is fully scraped off from the corneal and Limbal areas. A good 
polishing and excellent smoothing can be attained using a diamond 
- tipped knife with continuous irrigation. If necessary a light field 
cautery can be applied. 
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  Meanwhile an adequate sized conjunctival auto graft 
tissue usually from supero temporal region by measuring across the 
limbus, its distance from the limbus, and maximum circumferential 
area of the graft is marked. The graft is then excised from its Forniceal 
end. On reaching the Limbal side the graft has to be flipped over the 
cornea. The graft should be fully separated from it Tenon‟s capsule. 
  The blood that is oozing out from the fractured vessels or 
a capillary is purposefully fractured in the scleral bed is now allowed 
to form a clot.. The graft oriented properly is spread over the bed and it 
is gently pressure for about 3 minute. Then wait for few more minutes. 
After checking for the stability of the graft the lid speculum is to be 
carefully removed. 
                     Tight secured pad and bandage was applied for next 24 
hours which helps in ensuring the graft position. All patients were put 
on antibiotics and steroid eye drops for the first week and further 
tapering. 
ASSESSMENT OF PARAMETERS 
                         A scoring was devised based on the pain sensitive 
response of the patient. Every patient was given the score on 
immediate first post operative day and end of first post operative week. 
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                       All the subjects underwent slit lamp bio microscopic 
examination. The graft stability assessment was done and also it was 
graded. 
Grade O     - well opposed four sites of the margin 
Grade 1      - displacement of one side of the graft bed junction 
Grade 2      - two sides of margins displaced being not apposed 
Grade 3      - three sides of margins not apposed, graft displaced 
Grade 4      - completely displaced graft with lack of apposition 
                    All the subjects were noted for graft loss, sub graft 
hemorrhage, graft retraction whose incidence was more common with 
chemosis, graft edema. Post operatively all the eyes which underwent 
surgery were analyzed for post operative   correction of astigmatism by 
doing K - reading. Every patient was followed for the next six months 
for their change in astigmatism in terms of k - reading, best corrected 
visual acuity and for symptomatic relief and for the disease recurrence. 
The mean difference between the corneal curvatures before and after 
surgery was recorded. 
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OBSERVATIONS 
                       Totally 40 eyes were studied. It included anyone 
above 35 years of age, including both males and females. All the 
subjects had a true pterygium and were nasally situated. About 5 
patients of the 40 underwent cataract surgery along with pterygium 
evaluation that included the biometric for IOL power calculation. All 
the subjects were followed for a minimum period of 6 months. 
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RESULTS AND INTERPRETATION 
 
AGE DISTRIBUTION 
Of the studied population 15 patients (37.5%) were between the 
age group of 36 to 45 years. 20 patients (50%) were in the age 
distribution of 46 to 55. And only 12.5% i.e 5 patients were in the age 
group between 56 to 60 years.  
Majority of the subjects taken for study were between 46 and 55 
years and less equal numbers were between 36 and 45 years. 
 
 
 
 
 
 
 
 
 
 
 
AGE Frequency Percent 
36 – 45 15 37.50% 
46 – 55 20 50.00% 
56 – 60 5 12.50% 
Total 40 100.00% 
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SEX DISTRIBUTION 
Of the 40 patients studied 24 (60%) were males and 20 patients (40%) 
were females.  
The study showed relative male preponderance which was attributed 
to their nature of work.   
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SEX Frequency Percent 
Male 24 60.00% 
Female 16 40.00% 
Total 40 100.00% 
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DISTRIBUTION OF COMPLAINTS 
Out of 40 patients, 19 cases (47.5%) presented with symptoms of 
ocular discomfort. 14 cases (35%) presented with symptoms of visual 
disturbances.  
2 cases (5%) purely presented for cosmetic purpose. 5 cases (12.5%) 
presented with symptoms of both visual disturbance and ocular discomfort. 
Majority of the patients who were taken for surgery, were for symptoms of 
ocular discomfort. Though 5% was a small percentage, they had valid 
purpose of cosmetic correction for which this study is accountable. 
 
 
 
 
 
 
 
COMPLAINTS Frequency Percent 
Visual Discomfort 14 35.00% 
Ocular Discomfort 19 47.50% 
Cosmetic Correction 2 5.00% 
Visual and Ocular Discomfort 5 12.50% 
Total 40 100.00% 
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VISUAL ACUITY AT TIME OF PRESENTATION 
16 patients (40%) had an UCVA of 6/36 - 6/18. Out of 40 patients, 13 
patients (32.5%) had an  UCVA of 6/12 - 6/9. 8 patients (20%) had an 
UCVA of 6/60 - 6/36. 3 patients (7.5%) presented with an UCVA of 6/9 - 
6/6.   
The least percentage included the patients who presented for cosmetic 
purpose. 
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UCVA Frequency Percent 
6/9 – 6/6 3 7.50% 
6/12 – 6/9 13 32.50% 
6/36 – 6/18 16 40.00% 
6/60 – 6/36 8 20.00% 
Total 40 100.00% 
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REFRACTIVE STATUS IN THE STUDY POPULATION 
 
57.5% of patients (23 out of 40) had with the rule astigmatism.  
11 patients (27.5%) had pre -existing astigmatism as their refractive status.  
4 patients (10%) had no visually significant refractive error.  
2 patients accounting 5% had pupillary axis involvement.  
62.5% of patients had significant astigmatism that had to be reversed with 
pterygium excision. 
 
 
REFRACTIVE STATUS Frequency Percent 
Pupillary Axis Involvement 2 5.00% 
With/Against the rule Astigmatism 23 57.50% 
Pre Existing Astigmatism 11 27.50% 
No Astigmatism (Emmetropic) 4 10.00% 
Total 40 100.00% 
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LENS OPACIFICATION 
About 75% of patients who accounted 30 in number had no lens 
opacification. Of the 40 only 10 (25%) patients had lens opacification.  
Only 5 of the 10 patients had significant lens opacification who underwent 
cataract surgery. 
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LENS 
OPACIFICATION 
Frequency Percent 
Present 10 25.00% 
Absent 30 75.00% 
Total 40 100.00% 
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GRADING OF PTERYGIUM   
Of the 40 eyes that underwent pterygium surgery 22 (55%) eyes had 
progressive pterygium. And 18 eyes (45%) had stationary pterygium. 
Though 45% of patients had stationary type they were notorious causing 
ocular discomfort and also a significant amount of astigmatism causing 
visual disturbance.  
 
 
 
 
 
 
 
 
 
 
GRADING OF PTERYGIUM Frequency Percent 
Progressive 22 55.00% 
Stationary 18 45.00% 
Total 40 100.00% 
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INCIDENCE OF PAIN ON FIRST POST OPERATIVE DAY  
Pain on day 1 post operatively is a significant index of assessment of 
the efficiency of the procedure. Compared to suturing fibrin adhesive 
is less painful. Compared to suture and fibrin adhesive as fixative, 
auto blood used as fixative produces no pain. In this prospective study 
only about 20% of patients had pain which proves the procedure to be 
efficacious. 
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PAIN ON POD 1 Frequency Percent 
Present 8 20.00% 
Absent 32 80.00% 
Total 40 100.00% 
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INCIDENCE OF GRAFT EDEMA ON FIRST POST OPERATIVE 
DAY  
Of the 40 eyes 97.5% i.e 39 patients had no accountable graft edema. 
Only 1 case out of 40 cases had graft edema.  
This study suggests that self limiting conjunctival graft edema occurs 
in early postoperative day invariably.  
Further a significant graft edema can be quantitatively analyzed using 
AS – OCT 
 
 
GRAFT EDEMA ON POD 1 Frequency Percent 
Present 1 2.50% 
Absent 39 97.50% 
Total 40 100.00% 
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INCIDENCE OFGRAFT RETRACTION/CHEMOSIS ON FIRST 
POST OPERATIVE DAY 
2 eyes of 2 patients which represent 5% of the study population had 
graft retraction. Patients who had chemosis also presented with graft 
retraction. 
These patients were conservatively managed successfully. 
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GRAFT RETRACTION/ CHEMOSIS 
ON POD 1 
Frequency Percent 
Present 2 5.00% 
Absent 38 95.00% 
Total 40 100.00% 
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INCIDENCE OFCOMPLAINTS ON FIRST POST OPERATIVE DAY 
Of the 40 patients 8 (20%) patients had complaints of mild discomfort 
on day 1 postoperatively.  
 
 
COMPLAINTS ON POD 1 Frequency Percent 
Absent 32 80.00% 
Present 8 20.00% 
Total 40 100.00% 
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COMPLAINTS ON SEVENTH POSTOPERATIVE DAY 
On day 7 postoperatively none of the patients had any specific 
complaints. This is clinically more significant. 
COMPLAINTS ON POD 7 Frequency Percent 
Absent 40 100.00% 
Present 00 00.00% 
Total 40 100.00% 
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ASTIGMATISM ON POSTOPERATIVE DAY 30 
 16 (40%) out of 40 subjects had some astigmatism at the end of 30 
days post surgery. 24 patients (60%) had no astigmatism at the end of 30 
days. Out of 62.5% of total number of astigmatism 60% got reversed. 
 The remaining 16 patients (40%) with astigmatism were accountable 
to the pre-existing astigmatism. And a minority of patients who underwent 
cataract extraction had the residual astigmatism. 
  
 
 
 
 
 
ASTIGMATISM ON POD 30 Frequency Percent 
Present 16 40.00% 
Absent 24 60.00% 
Total 40 100.00% 
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ASTIGMATISM ON DAY 180 POSTOPERATIVELY 
On day 180 after surgery 11 (27.5) out of 40 patients had some 
astigmatism uncorrected. In 29 (72.5%) patients there was no astigmatism, 
which included the corrected refractive errors because of encroachment of 
papillary axis( 5%), astigmatism due to pterygium causing refractive 
errors(57.5%) and also the already emmetropes(10%) who reminded as such. 
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ASTIGMATISM ON POD 180 Frequency Percent 
Present 11 27.50% 
Absent 29 72.50% 
Total 40 100.00% 
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RECURRENCE ON DAY 180 POSTOPERATIVELY 
Recurrence Rate: 0% 
 
 
 
 
 
 
 
RECURRENCE ON POD 180 Frequency Percent 
Present 00 00.00% 
Absent 40 100.00% 
Total 40 100.00% 
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ASTIGMATISM ON 180
TH
  POST OPERATIVE DAY 
PRE 
OPERATIVELY 
PRESENT ABSCENT TOTAL 
PRESENT 11 22 33 
Row% 33.33% 66.67% 100.00% 
Col% 100.00% 75.86% 82.50% 
ABSENT 0 7 7 
Row% 0.00% 100.00% 100.00% 
Col% 0.00% 24.14% 17.50% 
TOTAL 11 29 40 
Row% 27.50% 72.50% 100.00% 
Col% 100.00% 100.00% 100.00% 
 
SINGLE TABLE ANALYSIS: 
 
STATISTICAL TESTS Chi-square  1-tailed p  2-tailed p  
Chi-square - uncorrected  3.2184  
 
0.0728162635 
Chi-square - Mantel-Haenszel 3.1379  
 
0.0764918610 
Chi-square - corrected (Yates) 1.7636  
 
0.1841735606 
Mid-p exact 
 
0.0418584219 
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A mid p value of 0.0418584219 which is less than 0.05 shows 
that there is a statistical difference between the pre operative and post 
operative astigmatism, thus accounting for the role of glueless 
sutureless conjunctival autograft technique in providing a better visual 
acuity with nil recurrence rate. 
 SUMMARY 
       The study conducted was a prospective one on the efficacy of glueless 
sutureless conjunctival auto graft fixation in pterygium. 40 patients were 
included in the study. All the patients taken in to the study satisfied the 
inclusion criteria and underwent screening procedure and were taken up for 
surgery. They were followed upon day 1,7,30,180. 
1. Age distribution 
  50% of patients were in the age group 46 to 55 years of age. 
This prevalence showed an association with the cumulative effect in the 
formation of pterygium with increasing age. 
2. Sex distribution 
  40% of the studied population was male. Though the study was 
in a literally smaller number of patients compared to the actual incidence as 
a tip of the iceberg, it showed a male preponderance of the disease. 
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3. Distribution of complaints 
  47.5% of patients had ocular discomfort as their complaints and 
35% had visual disturbance. And 2% of patients submitted themselves for 
cosmetic purpose. Only 12.5% patients had complaints of both visual 
disturbance and ocular discomfort. 
4. Visual acuity at the time of presentation 
  40% of patients presented UCVA of 6/36 to 6/18. 2% patients 
who presented for cosmetic correction showed UCVA of 6/9 to 6/6. 8% of 
patients also showed lens opacification. 
5. Refractive status 
  57.5% patients had astigmatism, of which majority were with 
the rule astigmatism. 27.5% had preexisting astigmatism. 5% had refractive 
error due to visual axis encroachment that also had astigmatism. 
6. Lens opacification 
  75% patients had no significant lens opacification. Only 25% of 
patients showed cataractous lens changes, of which only 5% of the 
population underwent cataract surgery simultaneously. 
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7. Grading of pterygium 
  55% patients showed progressive pterygium and 45% had 
stationary pterygium. This 45% stationary pterygium was notorious causing 
ocular discomfort and significant astigmatism. 
8. Pain on day 1 
  Only 20% of patients experienced pain on day 1 
postoperatively. Immediate postoperative pain being a significant index of 
assessment of the procedure, the technique proves to be efficacious. 
 
9.  Graft edema 
  Though during the early postoperative period increased graft 
thickness is common with the conjunctival auto graft, only 2.5% of the 
patients had graft edema. 
10. Graft retraction/chemosis on day 1 
  Only 5% of patients had graft retraction that also had chemises. 
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11. Complaints on day 1 and 7 
  Only 2% of patients had complaints. This was clinically more 
significant. 
  At the end of 7 days none of the patients had any complaints. 
12. Astigmatism on day 30 and 180 
  Study showed 40% of patients with astigmatism at the end of 
30 days. At the end of 180 days only 27.5% had astigmatism. 72.5% had no 
astigmatism on 180 Th days which included the corrected refractive error 
due to visual axis involvement, pterygium induced astigmatism and the 
emmetropes in the study group. 
13. Recurrence analysis 
  The mid p value of 0.0418584219 which is less than 0.05 shows 
that there is statistical difference between the preoperative and postoperative 
astigmatism thus accounting for the role of glueless sutureless technique in 
autograft fixation in providing a better visual acuity with low rate of 
recurrence in a good surgeon‟s hands. 
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DISCUSSION 
There are a number of surgical procedures that are available and have 
been recommended like excision of pterygium and a bare sclera, with 
adjunctive like beta irradiation, mitomycin c application, amniotic 
membrane transplantation and rotational auto graft. 
The following are the principle goal to be achieved by any approach 
for pterygium  
  1) No complications due to surgery 
  2) A low recurrence rate 
  3) Good cosmesis 
  4) Cost benefit 
The prime benefit of an auto graft is preserving and restoration the 
anatomy of conjunctiva and its interface with cornea in a more 
physiological pattern. That is why conjunctival auto graft is supreme to 
all the available treatment techniques and more widely accepted. 
Though a good and safe procedures it has certain short comings like 
time duration for surgery, number of sutures that are required to hold 
the graft, suture related complications like irritation, discomfort, suture 
related infections and granuloma formation. 
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Tissue adhesives like tisseel- fibrin glue can help in tackling the 
complications produced by sutures. They mimic the natural wound 
healing process and final stages of coagulation cascade helps in 
adhesion of the graft without producing scar formation.  
The greatest disadvantage of this procedure is its cost and others like 
reported virus infection, antigenic response to its constituents.In the 
procedure taken for the study purpose neither suture nor fibrin glue 
was used. The main drawback of the study is it did not have control 
group of suture and fibrin glue applied eyes. The efficacy of the 
procedure was studied with the already done suture related treatment 
outcome in a retrospective basis. The mid p value of 0.0418584219 
which is less than 0.05 shows that there is statistical difference 
between the pre-operative and post-operative astigmatism which is 
significant proves glueless sutureless conjunctival autograft technique 
a superior one. 
The corneal curvature and the measured cylinders before and 
after surgery showed significant statistical changes and bought an 
improvement in the visual acuity because of a decrease in cylinders. 
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CONCLUSION 
The study on efficacy on glueless sutureless conjunctival 
auto graft in pterygium surgery shows statistically significant 
results in visual acuity improvement, comfort for the patient and 
a low recurrence.   
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PART THREE 
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PROFORMA 
 
EFFICACY OF GLUELESS SUTURELESS AUTOGRAFT FIXATION IN PTERYGIUM SURGERY 
 
Se No  OP No            IP No  
Name              Age Sex 
              Occupation  
              Domicile  
Contact phone number             Educational Qualification 
Chief complaints           Duration 
Laterality OD / OS / Both Eyes                          Restricted mobility Yes / No                        H/O previous surgery Yes / No 
ON EXAMINATION    
OD  OS 
 
 
 
Diagram 
 
 
 
 
Conjunctiva  
 Severity of congestion 
 
 
 
Cornea  
Encroachment in mm. 
 
 Extra ocular mobility               
 Visual acuity &  
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Correction 
 
 Preoperative K Reading  
 Tear film stability                       
 Type of pterygium  
 
 
Others 
 
 
 
 
 Treatment   
 Date & Type of surgery  
 Postoperative K Reading  
 Final outcome  
OD  OS 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Recurrence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
Follow up visit S/L 
Day 1 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Recurrence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Follow up visit S/L 
Week 1 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
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Recurrence Yes / No 
 
Recurrence Yes / No 
 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Recurrence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
Follow up visit S/L 
Month 1 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Recurrence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Recurrence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
Follow up visit S/L 
Month 6 
Hemorrhage wound gape 
Graft shrinkage 
Chemosis 
Graft dehiscence 
Recurrence 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
 Post-operative visual 
acuity 
 
 Remarks 
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Name Age Sex Complaints L UCVA BCVA RE Grading On POD 1 On POD 7 On POD 30 On POD 180 
         
PAIN GE GR/C SCH DEHI NC 
PAI
N GE/R/C DEHI NC 
GE
/R
/C ASTIG 
RE
CC ASTIG 
Rani 36 F Cosmetic Absent 6/6 6/6 Emmetropic Stationary Yes No No No No Yes No No No Yes No Absent No Absent 
Muthu Irulayi 42 F Visual Disturbance Absent 6/24 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Vimala 44 F Visual Disturbance Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Fathima Bi 43 F Ocular Discomfort Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Anish Begum 41 F Ocular Discomfort Absent 6/12 6/9 Pre existing Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Present 
Arjunan 37 M Cosmetic Absent 6/6 6/6 Emmetropic Stationary No No No No No No No No No Yes No Absent No Absent 
Senthilnathan 40 M Ocular Discomfort Absent 6/24 6/9 Astigmatism Stationary No No No No No No No No No Yes No 
Presen
t No Absent 
Mariyappadeva
r 37 M Ocular Discomfort Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Malayan 38 M Ocular Discomfort Absent 6/12 6/6 Astigmatism Stationary No No No No No No No No No Yes No Absent No Absent 
Sengattan 38 M Ocular Discomfort Absent 6/12 6/9 Pre existing Astigmatism Stationary No No No No No No No No No Yes No 
Presen
t No Present 
Raju 36 M Ocular Discomfort Absent 6/12 6/9 Pre existing Astigmatism Stationary No No No No No No No No No Yes No 
Presen
t No Present 
Ramesh 37 M Ocular Discomfort Absent 6/9 6/9 Pre existing Astigmatism Stationary No No No No No No No No No Yes No 
Presen
t No Present 
Arumugam 39 M Visual Disturbance Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Veerapandi 36 M Visual Disturbance Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Muthu 40 M Visual Disturbance Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Sumathi 47 F Visual Disturbance Present 6/36 6/36 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Radha 46 F Visual Disturbance Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Absent 
Ochayee 48 F Visual Disturbance Absent 6/12 6/9 Pre existing Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Present 
Virumayee 49 F Ocular Discomfort Absent 6/18 6/6 Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Absent 
Nalini 51 F Ocular Discomfort Absent 6/18 6/9 Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Absent 
Azhagamma 55 F Ocular Discomfort Absent 6/18 6/9 Astigmatism Progressive Yes Yes No No No Yes No No No Yes No 
Presen
t No Absent 
Pechiammal 53 F Ocular Discomfort Absent 6/9 6/9 Astigmatism Stationary No No No No No No No No No Yes No Absent No Absent 
Pichammal 52 F Ocular Discomfort Absent 6/12 6/9 Pupillary Axis Involoved Stationary Yes No No No No Yes No No No Yes No Absent No Absent 
Rajavelu 55 M Visual Disturbance Present 6/60 6/24 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Karuppan 54 M Visual Disturbance Present 6/36 6/24p Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Angaiyan 52 M Visual Disturbance Present 6/36 6/18p Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
Adaikkan 53 M Visual Disturbance Absent 6/36 6/9 Astigmatism Progressive No No No No No No No No No Yes No Absent No Absent 
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Arockiam 51 M Visual Disturbance Absent 6/18 6/9 Pre existing Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Present 
Dasthagir 47 M Visual Disturbance Absent 6/18 6/9 Pre existing Astigmatism Progressive No No No No No No No No No Yes No 
Presen
t No Present 
Vijay 48 M Ocular Discomfort Present 6/12p 6/12 Astigmatism Stationary No No No No No No No No No Yes No Absent No Absent 
Muthiah 47 M Ocular Discomfort Absent 6/12p 6/6 Astigmatism Stationary No No No No No No No No No Yes No Absent No Absent 
Palsamy 48 M Ocular Discomfort Absent 6/9 6/9 Astigmatism Stationary No No No No No No No No No Yes No Absent No Absent 
Pulugandi 52 M Ocular Discomfort Absent 6/9p 6/9 Astigmatism Stationary No No No No No No No No No Yes No Absent No Absent 
Sadayan 51 M Ocular Discomfort Absent 6/6 6/6 Emmetropic Stationary No No No No No No No No No Yes No Absent No Absent 
Mookan 50 M Ocular Discomfort Absent 6/6 6/6 Emmetropic Stationary No No No No No No No No No Yes No Absent No Absent 
Shanmugathai 57 F Visual and Ocular Discomfort Present 6/60 6/36 Pupillary Axis Involoved Progressive Yes No Yes No No Yes No No No Yes No Absent No Absent 
Munusamy 56 M Visual and Ocular Discomfort Present 6/60 6/24 Pre existing Astigmatism Stationary Yes No Yes No No Yes No No No Yes No 
Presen
t No Present 
Oomathevar 58 M Visual and Ocular Discomfort Present 6/60 6/24 Pre existing Astigmatism Stationary Yes No No No No Yes No No No Yes No 
Presen
t No Present 
Sarala 60 F Visual and Ocular Discomfort Present 6/60 6/36 Pre existing Astigmatism Progressive Yes No No No No Yes No No No Yes No 
Presen
t No Present 
Kathayee 59 F Visual and Ocular Discomfort Present 6/36 6/36 Pre existing Astigmatism Stationary Yes No No No No Yes No No No Yes No 
Presen
t No Present 
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